7,366 results on '"Schistosoma haematobium"'
Search Results
2. The abundance of snail hosts mediates the effects of antagonist interactions between trematodes on the transmission of human schistosomes.
- Author
-
Douchet, Philippe, Haegeman, Bart, Allienne, Jean-François, Boissier, Jérôme, Senghor, Bruno, and Rey, Olivier
- Subjects
- *
SCHISTOSOMA haematobium , *FRESHWATER biodiversity , *CERCARIAE , *SPECIES diversity , *TREMATODA - Abstract
Background: Combating infectious diseases and halting biodiversity loss are intertwined challenges crucial to ensure global health. Biodiversity can constrain the spread of vector-borne pathogens circulation, necessitating a deeper understanding of ecological mechanisms underlying this pattern. Our study evaluates the relative importance of biodiversity and the abundance of Bulinus truncatus, a major intermediate host for the trematode Schistosoma haematobium on the circulation of this human pathogen at aquatic transmission sites. Methods: We combined mathematical modelling and a molecular based empirical study to specifically assess the effect of co-infections between S. haematobium and other trematodes within their B. truncatus snail hosts; and B. truncatus abundance at transmission sites, on the production of S. haematobium infective cercariae stages released into the aquatic environment. Results: Our modelling approach shows that more competitive trematode species exploiting B. truncatus as an intermediate host at the transmission site level leads to higher co-infection rates within snail hosts, subsequently reducing the production of S. haematobium cercariae. Conversely, an increase in B. truncatus abundance results in lower co-infection rates, and a higher proportion of S. haematobium cercariae released into the environment. Our empirical data from the field support these findings, indicating a significant negative effect of local trematode species richness (P-value = 0.029; AIC = 14.9) and co-infection rates (P-value = 0.02, AIC = 17.4) on the dominance of S. haematobium based on our GLMM models, while B. truncatus abundance positively influences S. haematobium dominance (P-value = 0.047, AIC = 20.1). Conclusions: Our study highlights the importance of biodiversity in influencing the transmission of S. haematobium through the effect of antagonistic interactions between trematodes within bulinid snail hosts. This effect intensifies when B. truncatus populations are low, promoting co-infections within snails. In line with the One Health concept, our results suggest that maintaining high level of freshwater biodiversity to sustain global trematode diversity at transmission sites can help reducing the circulation of Schistosoma species locally. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Effects of Schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review.
- Author
-
Mertelsmann, Anna M., Bowers, Sheridan F., Wright, Drew, Maganga, Jane K., Mazigo, Humphrey D., Ndhlovu, Lishomwa C., Changalucha, John M., and Downs, Jennifer A.
- Subjects
- *
REGULATORY B cells , *REGULATORY T cells , *CELL transformation , *SCHISTOSOMA haematobium , *P53 antioncogene - Abstract
Background: Urogenital schistosomiasis caused by Schistosoma haematobium affects approximately 110 million people globally, with the majority of cases in low- and middle-income countries. Schistosome infections have been shown to impact the host immune system, gene expression, and microbiome composition. Studies have demonstrated variations in pathology between schistosome subspecies. In the case of S. haematobium, infection has been associated with HIV acquisition and bladder cancer. However, the underlying pathophysiology has been understudied compared to other schistosome species. This systematic review comprehensively investigates and assimilates the effects of S. haematobium infection on systemic and local host mucosal immunity, cellular gene expression and microbiome. Methods: We conducted a systematic review assessing the reported effects of S. haematobium infections and anthelmintic treatment on the immune system, gene expression and microbiome in humans and animal models. This review followed PRISMA guidelines and was registered prospectively in PROSPERO (CRD42022372607). Randomized clinical trials, cohort, cross-sectional, case-control, experimental ex vivo, and animal studies were included. Two reviewers performed screening independently. Results: We screened 3,177 studies and included 94. S. haematobium was reported to lead to: (i) a mixed immune response with a predominant type 2 immune phenotype, increased T and B regulatory cells, and select pro-inflammatory cytokines; (ii) distinct molecular alterations that would compromise epithelial integrity, such as increased metalloproteinase expression, and promote immunological changes and cellular transformation, specifically upregulation of genes p53 and Bcl-2; and (iii) microbiome dysbiosis in the urinary, intestinal, and genital tracts. Conclusion: S. haematobium induces distinct alterations in the host's immune system, molecular profile, and microbiome. This leads to a diverse range of inflammatory and anti-inflammatory responses and impaired integrity of the local mucosal epithelial barrier, elevating the risks of secondary infections. Further, S. haematobium promotes cellular transformation with oncogenic potential and disrupts the microbiome, further influencing the immune system and genetic makeup. Understanding the pathophysiology of these interactions can improve outcomes for the sequelae of this devastating parasitic infection. Author summary: The parasitic trematode S. haematobium affects 110 million people worldwide. Many studies have described the effects of schistosome infections on humans and animals, but data focusing solely on S. haematobium infections, which cause urogenital schistosomiasis are scarce. Our goal was to evaluate, in a systematic manner, how S. haematobium infection affects the immune system, gene expression and microbiome of the host. These effects are important because they could lead to increased risk of infections, such as HIV, and bladder cancer. We screened 3,179 studies for potential relevance and included 94 of them in this review. Our analysis showed that S. haematobium infection profoundly alters the immune system with a mixed pro-inflammatory and anti-inflammatory response, though with a predominant type 2 immune phenotype and increased regulatory cells. We further found consistent evidence that it impairs local mucosal epithelial barrier integrity, promotes cellular transformation with pro-oncogenic changes in the host, and is associated with microbial alterations in urine, stool, and genital tracts. We discuss how these findings might be interpreted, and the additional research needed, to improve our understanding of S. haematobium pathophysiology and ameliorate the potential sequelae of S. haematobium infection, such as increased viral infections and cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Prevalence and correlations of schistosomiasis mansoni and schistosomiasis haematobium among humans and intermediate snail hosts: a systematic review and meta-analysis.
- Author
-
Wang, Xin-Yao, Li, Qin, Li, Yin-Long, Guo, Su-Ying, Li, Shi-Zhu, Zhou, Xiao-Nong, Guo, Jia-Gang, Bergquist, Robert, Juma, Saleh, Zhang, Jian-Feng, Yang, Kun, and Xu, Jing
- Subjects
- *
RANDOM effects model , *SCHISTOSOMA haematobium , *SCHISTOSOMA mansoni , *BIOMPHALARIA , *SCHISTOSOMIASIS - Abstract
Background: The control of schistosomiasis is particularly difficult in sub-Saharan Africa, which currently harbours 95% of this disease. The target population for preventive chemotherapy (PC) is expanded to all age group at risk of infection, thus increasing the demands of praziquantel (PZQ) tablets according to the new released guideline by World Health Organization. Due to the gap between available PZQ for PC and requirements, alternative approaches to assess endemicity of schistosomiasis in a community, are urgently needed for more quick and precise methods. We aimed to find out to which degree the infection status of snails can be used to guide chemotherapy against schistosomiasis. Methods: We searched literature published from January 1991 to December 2022, that reported on the prevalence rates of Schistosoma mansoni, S. haematobium in the intermediate snails Biomphalaria spp. and Bulinus spp., respectively, and in humans. A random effect model for meta-analyses was used to calculate the pooled prevalence estimate (PPE), with heterogeneity assessed using I-squared statistic (I2), with correlation and regression analysis for the exploration of the relationship between human S. mansoni and S. haematobium infections and that in their specific intermediate hosts. Results: Forty-seven publications comprising 59 field investigations were included. The pooled PPE of schistosomiasis, schistosomiasis mansoni and schistosomiasis haematobium in humans were 27.5% [95% confidence interval (CI): 24.0–31.1%], 25.6% (95% CI: 19.9–31.3%), and 28.8% (95% CI: 23.4–34.3%), respectively. The snails showed an overall infection rate of 8.6% (95% CI: 7.7–9.4%), with 12.1% (95% CI: 9.9–14.2%) in the Biomphalaria spp. snails and 6.9% (95% CI: 5.7–8.1%) in the Bulinus spp. snails. The correlation coefficient was 0.3 (95% CI: 0.01–0.5%, P < 0.05) indicating that the two variables, i.e. all intermediate host snails on the one hand and the human host on the other, were positively correlated. Conclusions: The prevalence rate of S. mansoni and S. haematobium is still high in endemic areas. Given the significant, positive correlation between the prevalence of schistosomes in humans and the intermediate snail hosts, more attention should be paid to programme integration of snail surveillance in future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Identification of Schistosoma haematobium and Schistosoma mansoni linear B-cell epitopes with diagnostic potential using in silico immunoinformatic tools and peptide microarray technology.
- Author
-
Vengesai, Arthur, Manuwa, Marble, Midzi, Herald, Mandeya, Masimba, Muleya, Victor, Mujeni, Keith, Chipako, Isaac, and Mduluza, Takafira
- Subjects
- *
RECOMBINANT proteins , *PEPTIDES , *SCHISTOSOMA haematobium , *AMINO acid sequence , *HELMINTHIASIS - Abstract
Introduction: Immunoinformatic tools can be used to predict schistosome-specific B-cell epitopes with little sequence identity to human proteins and antigens other than the target. This study reports an approach for identifying schistosome peptides mimicking linear B-cell epitopes using in-silico tools and peptide microarray immunoassay validation. Method: Firstly, a comprehensive literature search was conducted to obtain published schistosome-specific peptides and recombinant proteins with the best overall diagnostic performances. For novel peptides, linear B-cell epitopes were predicted from target recombinant proteins using ABCpred, Bcepred and BepiPred 2.0 in-silico tools. Together with the published peptides, predicted peptides with the highest probability of being B-cell epitopes and the lowest sequence identity with proteins from human and other pathogens were selected. Antibodies against the peptides were measured in sera, using peptide microarray immunoassays. Area under the ROC curve was calculated to assess the overall diagnostic performances of the peptides. Results: Peptide AA81008-19-30 had excellent and acceptable diagnostic performances for discriminating S. mansoni and S. haematobium positives from healthy controls, with AUC values of 0.8043 and 0.7326 respectively for IgG. Peptides MS3_10186-123-131, MS3_10385-339-354, SmSPI-177-193, SmSPI-379-388, MS3-10186-40-49 and SmS-197-214 had acceptable diagnostic performances for discriminating S. mansoni positives from healthy controls with AUC values ranging from 0.7098 to 0.7763 for IgG. Peptides SmSPI-359-372, Smp126160-438-452 and MS3 10186-25-41 had acceptable diagnostic performances for discriminating S. mansoni positives from S. mansoni negatives with AUC values of 0.7124, 0.7156 and 0.7115 respectively for IgG. Peptide MS3-10186-40-49 had an acceptable diagnostic performance for discriminating S. mansoni positives from healthy controls, with an AUC value of 0.7413 for IgM. Conclusion: One peptide with a good diagnostic performance and nine peptides with acceptable diagnostic performances were identified using the immunoinformatic approach and peptide microarray validation. There is need for evaluation of the peptides with true negatives and a good standard positive reference. Author summary: Schistosomiasis, commonly known as bilharzia, is the third most significant tropical disease after malaria and soil-transmitted helminthiases. Like other neglected tropical diseases common in Zimbabwe, schistosomiasis remains mostly undiagnosed or undetected. This is partly due to the fact that reliable identification of parasites requires expertise for specimen preparation, and microscopic examination. Unfortunately, this level of expertise is unavailable in most rural clinics. This limitation is further compounded by the fact that the recommended microscopy-based methods for schistosomiasis diagnosis lack sensitivity, especially in infections of low intensity. To overcome some of the problems associated with microscopy-based methods, highly sensitive serological tests have been utilized. Unfortunately, currently available serological tests have low specificity and show cross-reactivity with other helminthic infections. One way to mitigate cross-reactivity and increase the specificity, is to use immunoinformatic tools and immunoassays to identify schistosomiasis species-specific immunogenic peptides mimicking B-cell epitopes (short amino acid sequences of the antigen that reacts with antibodies). Utilizing immunoinformatic tools coupled with peptide microarray immunoassay validation approach several peptides that can be used to develop diagnostic tools for showing exposure to infection for people living in non-endemic or low-transmission areas were identified in the current study. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Clinical sensitivity and time-to-result of a cascaded pooled testing approach for assessing the prevalence and intensity of Schistosoma haematobium infection.
- Author
-
Degarege, Abraham, Levecke, Bruno, Negash, Yohannes, Animut, Abebe, and Erko, Berhanu
- Subjects
- *
SCHISTOSOMA haematobium , *SCHOOL children , *URINALYSIS , *URINE , *DIAGNOSIS methods - Abstract
Background: This study compared the clinical sensitivity and the time-to-result of an individual testing (IT) and a cascaded pooled testing approach (CPT; a positive test result in a pooled sample triggers examination of smaller-sized pools or individual samples) for assessing the prevalence and the intensity of Schistosoma haematobium infection. We also compared the sensitivity of the CPT in detecting S. haematobium infection when deploying urine filtration microscopy (UFM) vs. urine reagent strips (URS), and testing 10 mL vs. 15 mL of urine. Methodology/Principal findings: Between October 2021 and April 2022, S. haematobium eggs were counted in urine samples collected from school-aged children living in the Afar and Gambella Regional States of Ethiopia. Urine samples were collected at baseline (n = 1,288), and one month after administration of praziquantel (n = 118). All urine samples were processed through both an IT and a CPT approach (pools of 5, 10, 20, and 40 individual samples), deploying UFM (10 mL) and URS (10 mL). In addition, 15 mL urine was processed through the CPT deploying UFM. At baseline, the prevalence of S. haematobium infection estimated when using UFM and deploying a CPT approach was significantly lower (17.3%) compared to an IT approach (31.5%). The clinical sensitivity of the CPT in detecting S. haematobium eggs was 51.7%. The sensitivity increased significantly as a function of increasing log transformed urine egg counts (UECs) of the individual samples (OR 2.71, 95%CI 1.63 ― 4.52). The sensitivity was comparable when the amount of urine examined was 10 mL (51.7%) vs. 15 ml (50.8%), and when UFM was used for testing vs. URS (51.5%). The mean log UECs estimated following the CPT approach was lower compared to the estimate by the IT (p <0.001). UECs of the individual samples estimated using the IT and CPT approaches were moderately correlated (r = 0.59 when 10 mL and 15 mL urine was examined after pooling). CPT reduced the time needed for processing urine samples and testing for S. haematobium infection by 29% with UFM and by 27.7% with URS. Conclusions/Significance: CPT based on UFM and URS techniques may help to rapidly identify areas with higher prevalence of S. haematobium infection (hotspots) in a population. However, the performance of this approach in estimating the prevalence of infection may be compromised, particularly in endemic areas with low intensity infection. Author summary: We examined the sensitivity and the time-to-result of a cascaded pooled testing approach for detecting and estimating the intensity of Schistosoma haematobium infection. Urine samples collected from school-aged children in the Afar and Gambella regions of Ethiopia were analyzed individually and in pools using both urine filtration microcopy (UFM) and urine reagent strips (URS). The cascaded pooled testing approach detected close to 52% of urine samples with S. haematobium eggs. The sensitivity increased as the egg count of the individual samples increased but was comparable when the amount of urine examined was 10 mL vs. 15 mL, and when the diagnostic test used was UFM vs. URS. Pooled testing reduced the time needed for processing urine samples and counting S. haematobium eggs by 29%. Pooled testing based on UFM may help rapidly identify areas with higher prevalence of S. haematobium infection in a population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Detection of male genital schistosomiasis (MGS) associated with human, zoonotic and hybrid schistosomes in Southern Malawi.
- Author
-
Kayuni, Sekeleghe, Cunningham, Lucas, Mainga, Bright, Kumwenda, Dingase, Jnr, David Lally, Chammudzi, Priscilla, Kapira, Donales, Namacha, Gladys, Chisale, Alice, Nchembe, Tereza, Kinley, Louis, Chibwana, Ephraim, Ntaba, Bessie, Chapweteka, Gilbert, Khumalo, Waleke, Chibowa, Henry, Kumfunda, Victor, Juhasz, Alexandra, Jones, Sam, and Archer, John
- Subjects
- *
SEXUALLY transmitted diseases , *SCHISTOSOMA haematobium , *HUMAN papillomavirus , *MEDICAL personnel , *TRICHOMONAS vaginalis - Abstract
Background: Male Genital Schistosomiasis (MGS) remains an often-overlooked chronic sequela of urogenital schistosomiasis in endemic areas of sub-Saharan Africa. As part of a 2-year longitudinal study on Hybridization of UroGenital Schistosomiasis (HUGS) in Malawi, a MGS sub-study was conducted to assess whether hybrid schistosomes were incriminated. Methods: During recruitment, demographic, health and socio-economic data were collected through individual questionnaire interviews in Mthawira community from Nsanje District along Shire River and Samama community from Mangochi District along Lake Malawi shoreline. Urine and semen samples were collected and analysed to determine the identity of schistosome infection. Urine filtration and microscopy, direct microscopy of semen and its sediments (after centrifugation) were performed. Thereafter, the sediments were examined by molecular DNA analysis with a novel two-tube real-time PCR assay. The participants were also screened for Human papilloma virus (HPV) and other sexually transmitted infections (STIs). Results: Twenty-two men were recruited for the sub-study, 8 in Nsanje District and 14 in Mangochi District, with a median age of 22.0 years. By microscopy, ten (45.7%) participants had Schistosoma ova in their urine, 11 (50.0%) in semen while 16 (72.7%) were positive by real-time PCR. One participant had both S. haematobium and S. mattheei ova in his semen, three showed symptoms, and one had a mixed infection of S. mansoni and possible S. haematobium-S. mattheei hybrid. Twelve men had detectable high-risk HPV serotypes 16, 18 and others while six had Trichomonas vaginalis and other STIs. Conclusion: Zoonotic and hybrid schistosomes can cause MGS similar to human schistosomes, which can be co-infected with HPV and STIs, thereby posing a new challenge in diagnosis, management and control measures in resource poor settings. Increased awareness of these infections among local communities and primary healthcare workers and improvement of disease management are needed and advocated. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Usefulness of real-time PCR for urogenital schistosomiasis diagnosis in preschool children in a high-prevalence area in Angola.
- Author
-
Mediavilla, Alejandro, Silgado, Aroa, Sánchez-Marqués, Raquel, Bocanegra, Cristina, Nindia, Arlette, Salvador, Fernando, Pintar, Zeferino, Martínez-Vallejo, Patricia, Rubio Maturana, Carles, Goterris, Lidia, Martínez-Campreciós, Joan, Aixut, Sandra, Oliveira-Souto, Inés, Aznar-Ruiz-de-Alegría, María Luisa, Espiau, María, Molina, Israel, and Sulleiro, Elena
- Subjects
- *
NEGLECTED diseases , *SCHISTOSOMA haematobium , *PRESCHOOL children , *URINARY organs , *SCHISTOSOMIASIS - Abstract
Background: Urogenital schistosomiasis caused by Schistosoma haematobium is highly endemic in the municipality of Cubal in Angola. Currently, diagnosis is based on the observation of S. haematobium eggs in urine samples by microscopy but this method has low sensitivity. Few studies have been performed using molecular techniques in high-prevalence areas for the detection of S. haematobium. The objective of this study is to evaluate the usefulness of real-time PCR as a diagnostic technique for urogenital schistosomiasis among preschool-age children and its correlation with morbidity data. Methods: A cross-sectional study was conducted in Cubal, Angola, involving 97 urine samples from preschool-age children analyzed by the dipstick test, microscopic examination of filtered urine, and real-time PCR. The diagnosis of urogenital schistosomiasis was based on microscopy and/or real-time PCR results. Clinical and ultrasonography evaluation was performed to rule out complications of schistosomiasis. Results: We detected a total of 64.95% of samples positive by real-time PCR and 37.11% by microscopy. The sensitivity of parasitological diagnosis of urogenital schistosomiasis by real-time PCR and microscopy was 95.45% and 54.55%, respectively, and the sensitivity of real-time PCR compared with microscopy was 91.67%. A positive real-time PCR result was significantly related to older age (mean = 3.22 years), detection of eggs by microscopy, and abnormal urine dipstick results (18.56% with proteinuria, 31.96% with leukocyturia, and 31.96% with microhematuria) (p-value<0.05). Ultrasound analysis showed that 23.94% of children had urinary tract abnormalities, and it was significantly related to the real-time PCR diagnosis (p-value<0.05). Conclusions: Real-time PCR is a more sensitive technique than microscopy for urinary schistosomiasis diagnosis in preschool-age children in Cubal. This increase in sensitivity would allow earlier diagnosis and treatment, thus reducing the morbidity associated with schistosomiasis in its early stages. Author summary: Schistosomiasis is a neglected tropical disease that causes approximately 200,000 deaths worldwide each year. Urogenital schistosomiasis is caused by Schistosoma haematobium, which ultimately leads to lesions in the urinary tract due to egg deposition by the parasite. The World Health Organization recommends regular mass administration of praziquantel to prevent chronicity of the disease in high-endemicity areas. Preschool children are one of the most vulnerable groups, however, only children over two years of age are included in these strategies. The diagnostic techniques commonly used in endemic areas for egg detection by microscopy and urine hematuria have major limitations due to their low sensitivity. These limitations lead to misdiagnosis and undetected infections may eventually lead to the chronic form of the disease. Real-time PCR and microscopy were used to diagnose urogenital schistosomiasis in preschool children in Cubal, a high-transmission municipality in Angola. Urinary tract lesions were assessed by ultrasound. Of the samples tested, 64.95% were positive by real-time PCR, compared with 37.11% by microscopy, indicating sensitivities of 95.45% and 54.55%, respectively. Ultrasound analysis showed urinary tract alterations in 23.94% of the children. The results suggest that transmission of urogenital schistosomiasis in preschool children in Cubal is higher than previously estimated. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. High sensitivity but low specificity of the risk factors and symptoms questionnaire in diagnosing female genital schistosomiasis among sexually active women with genital lesions in selected villages of Maswa District, North-Western Tanzania.
- Author
-
Mbwanji, Gladys, Ndaboine, Edgar, Yusuf, Amina Jumanne, Kabona, George, Marwa, Boniface, and Mazigo, Humphrey D.
- Subjects
- *
MEDICAL personnel , *HEALTH facilities , *NEGLECTED diseases , *SCHISTOSOMA haematobium , *CHILDBEARING age - Abstract
Background: The diagnosis of Female Genital Schistosomiasis (FGS) which is a clinical feature of urogenital schistosomiasis caused by Schistosoma haematobium is challenging, especially in primary healthcare facilities characterized by low resources which are dependent by the majority of the FGS endemic communities. To facilitate and improve diagnosis in these settings, a simple risk factors and symptoms tool has been developed to help healthcare workers at primary healthcare facilities identify and manage FGS cases. However, the sensitivity and specificity of the tool are not known. Therefore, the objective of this study was to assess the performance of risk factors and symptoms tools in diagnosing FGS in adolescent girls and women of reproductive age in selected villages of north-western Tanzania. Methods: A community-based analytical cross-sectional study was conducted among 347 women aged 18–49 years in Maswa District, north-western Tanzania. A single urine sample was collected from each participant and screened for S. haematobium eggs using a urine filtration technique. Consenting participants (n = 177), underwent thorough speculum examination by trained gynaecologists using a digital portable colposcopy to capture images of the cervix and vagina. All the captured pictures were examined independently by two pairs (2 gynaecologists in each pair) of qualified obstetricians and gynaecologists. A descriptive analysis and logistic regression were used to demonstrate the prevalence, symptoms, and risk factors of FGS. Results: The mean age of 347 women enrolled in the study was 30 years (Standard Deviation (SD) ±7.7) and the prevalence of women with symptoms suggestive of FGS was 15.8% (95% CI; 10.8%- 22.0) by colposcope and 87% (95% CI; 83.0%-90.4%) using the risk factor and symptom checklist. The overall sensitivity, specificity, positive and negative predictive value of symptoms and risk factors checklist tool for diagnosing FGS schistosomiasis (≥7 score points) using colposcope as a reference test were 85.7% (95%CI; 80.6%- 90.9%), 8.7% (95%CI; 4.6%-12.9%), 15.0% (95%CI; 9.7%-20.3%) and 76.5% (95%CI; 70.2%-82.7%). Multivariate analysis showed that female genital schistosomiasis using a risk factor and symptom checklist was associated with fetching water in contaminated fresh water (aOR:21.8, 95%CI;2.8–171.2, P <0.003), self-reported pelvic pain (aOR:5.3, 95%CI; 1.1–25.9, P< 0.04) and having any urinary symptoms (aOR:12.2, 95%CI; 1.5–96.3, P<0.018). Urine microscopy results were available for 345 participants, of these, 3.5% (12/345) (95% CI; 1.8%-6.0%) were positive for S. haematobium infection. Conclusion: Female genital schistosomiasis and urinary-related symptoms are common in the current study population. The risk factor and symptoms checklist for diagnosis of FGS achieved high sensitivity but low specificity for women who scored ≥7 points using colposcope as a reference diagnostic test. At present, the call to integrate FGS into the reproductive health services for women has received much attention, however, the diagnostic part of FGS remains a challenge, thus there is a need to continue evaluating this tool in different population and age structures in endemic areas. Author summary: Female genital schistosomiasis (FGS) is a genital manifestation of a waterborne parasitic disease caused by Schistosoma haematobium, however, it is mostly neglected. FGS diagnosis is still a challenge due to the lack of reference standards for its diagnosis. Colposcope has been used as a standard for diagnosing FGS, it shows the FGS clinical findings on the cervix and vagina. However, FGS diagnosis by colposcope has not been feasible in most rural endemic settings due to its unavailability, low level of knowledge of its use for diagnosing FGS, and low FGS knowledge among healthcare workers. Thus, there is a need to develop an alternative cheap diagnostic tool to be used in endemic areas for identifying women and adolescent girls at high risk of having FGS lesions and referring them for colposcopy examination. This call has been given more weight by the WHO in its roadmap plan for ending Neglected Tropical Diseases (NTD) by 2030. In response to this call, this study determined the sensitivity and specificity of the risk factors and symptoms checklist (variables), and the prevalence of FGS by both colposcope and risk factors and symptoms checklist using a score point of 7 as a cut-off point to suspect FGS. Furthermore, we also determined the prevalence of S. haematobium infection using a urine filtration technique and determined the symptoms and risk factors of urogenital schistosomiasis among women in selected villages of Maswa district, north-western Tanzania. The findings of this study demonstrated a high prevalence of FGS in the current study population using both methods/diagnoses. There is a need for further evaluation of the performance of the risk and symptoms questionnaire to improve its performance. Furthermore, there is a need to integrate the FGS services into a wide spectrum of reproductive health services, to allow women with urogenital symptoms to receive treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Refining the Schistosoma haematobium recombinase polymerase amplification (Sh-RPA) assay: moving towards point-of-care use in endemic settings.
- Author
-
Donnelly, Owain, Mesquita, Silvia, Archer, John, Ali, Said M., Bartonicek, Zikmund, Lugli, Elena B., and Webster, Bonnie L.
- Subjects
- *
SCHISTOSOMA haematobium , *BETAINE , *POLYMERASES , *RECOMBINASES , *NUCLEIC acid isolation methods , *RESOURCE-limited settings , *ARTIFICIAL chromosomes , *TREMATODA - Abstract
Background: Urogenital schistosomiasis is caused by the parasitic trematode Schistosoma haematobium. Sensitive and specific point-of-care diagnostics are needed for elimination of this disease. Recombinase polymerase amplification (RPA) assays meet these criteria, and an assay to diagnose S. haematobium has been developed (Sh-RPA). However, false-positive results can occur, and optimisation of reaction conditions to mitigate these is needed. Ease of use and compatibility of DNA extraction methods must also be considered. Methods: Using synthetic DNA, S. haematobium genomic DNA (gDNA), and urine samples from clinical cases, Sh-RPA reactions incorporating different betaine concentrations (0 M, 1 M, 2.5 M, 12.5 M) and the sample-to-water ratios were tested to determine effects on assay specificity and sensitivity. In addition, five commercial DNA extraction kits suitable for use in resource-limited settings were used to obtain gDNA from single S. haematobium eggs and evaluated in terms of DNA quality, quantity, and compatibility with the Sh-RPA assay. All samples were also evaluated by quantitative polymerase chain reaction (qPCR) to confirm DNA acquisition. Results: The analytical sensitivity of the Sh-RPA with all betaine concentrations was ≥ 10 copies of the synthetic Dra1 standard and 0.1 pg of S. haematobium gDNA. The addition of betaine improved Sh-RPA assay specificity in all reaction conditions, and the addition of 2.5 M of betaine together with the maximal possible sample volume of 12.7 µl proved to be the optimum reaction conditions. DNA was successfully isolated from a single S. haematobium egg using all five commercial DNA extraction kits, but the Sh-RPA performance of these kits varied, with one proving to be incompatible with RPA reactions. Conclusions: The addition of 2.5 M of betaine to Sh-RPA reactions improved reaction specificity whilst having no detrimental effect on sensitivity. This increases the robustness of the assay, advancing the feasibility of using the Sh-RPA assay in resource-limited settings. The testing of commercial extraction kits proved that crude, rapid, and simple methods are sufficient for obtaining DNA from single S. haematobium eggs, and that these extracts can be used with Sh-RPA in most cases. However, the observed incompatibility of specific kits with Sh-RPA highlights the need for each stage of a molecular diagnostic platform to be robustly tested prior to implementation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Prevalence and associated factors of schistosomiasis among pregnant women in northern Senegal.
- Author
-
Ndiour, Coumba Nar, Senghor, Bruno, Thiam, Ousmane, Niang, Souleymane, Wotodjo, Amélé Nyedzie, Faye, Babacar Thiendella, Ndiaye, Ndeye Amy, Sow, Omar, Sylla, Khadime, Ndiaye, Magatte, Gaye, Oumar, Faye, Babacar, Sokhna, Cheikh, Doucouré, Souleymane, and Sow, Doudou
- Subjects
- *
PREGNANT women , *SCHISTOSOMIASIS , *SCHISTOSOMA haematobium , *SCHISTOSOMA mansoni , *PREGNANCY complications - Abstract
Background: Schistosomiasis remains a public health concern worldwide. It is responsible for more than 240 million cases in 78 countries, 40 million of whom are women of childbearing age. In the Senegal River basin, both Schistosoma haematobium and Schistosoma mansoni are very prevalent in school-age children. However, there is a lack of information on the burden of schistosomiasis in pregnant women, which can cause complications in the pregnancy outcome. This study aimed to determine the prevalence and associated factors of schistosomiasis in pregnant women. Methods: We conducted a prospective cross-sectional study of pregnant women attending antenatal clinics at the health center of the Senegalese Sugar Company and at the hospital of Richard Toll between August and December 2021. The urine and stool samples collected were examined using microscopy techniques and quantitative polymerase chain reaction (qPCR) to detect the presence of S. haematobium and S. mansoni. The urines were previously tested using urine reagent strips to detect hematuria and proteinuria. Socio-demographical, clinical, and diagnostically data were recorded by the midwife and the gynaecologist. The data were analyzed using a logistic regression model. Results: Among the 298 women examined for the infection by microscopic, 65 (21.81%) were infected with urogenital schistosomiasis, 10 (3.36%) with intestinal schistosomiasis, and 4 (1.34%) were co-infected with both types of schistosomiasis. Out of the 288 samples tested by qPCR, 146 (48.99%) were positive for S. haematobium, 49 (35.51%) for S. mansoni and 22 (15.94%) for both species (co-infection). Pregnant women having microscopic haematuria and proteinuria were significantly more infected (p < 0.05). Conclusion: This study has revealed a high prevalence of schistosomiasis in pregnant women in Senegal. The qPCR allowed us to detect more cases compared to the microscopy. There is a need to conduct more studies to understand the real burden of the disease and to set up a surveillance system to prevent pregnancy-related complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Schistosoma haematobium and Schistosoma bovis first generation hybrids undergo gene expressions changes consistent with species compatibility and heterosis.
- Author
-
Mathieu-Bégné, Eglantine, Kincaid-Smith, Julien, Chaparro, Cristian, Allienne, Jean-François, Rey, Olivier, Boissier, Jérôme, and Toulza, Eve
- Subjects
- *
SCHISTOSOMA haematobium , *GENE expression , *HETEROSIS , *BLOOD parasites , *SPECIES , *INTROGRESSION (Genetics) - Abstract
When two species hybridize, the two parental genomes are brought together and some alleles might interact for the first time. To date, the extent of the transcriptomic changes in first hybrid generations, along with their functional outcome constitute an important knowledge gap, especially in parasite species. Here we explored the molecular and functional outcomes of hybridization in first-generation hybrids between the blood fluke parasites Schistosoma haematobium and S. bovis. Through a transcriptomic approach, we measured gene expression in both parental species and hybrids. We described and quantified expression profiles encountered in hybrids along with the main biological processes impacted. Up to 7,100 genes fell into a particular hybrid expression profile (intermediate between the parental expression levels, over-expressed, under-expressed, or expressed like one of the parental lines). Most of these genes were different depending on the direction of the parental cross (S. bovis mother and S. haematobium father or the reverse) and depending on the sex. For a given sex and cross direction, the vast majority of genes were hence unassigned to a hybrid expression profile: either they were differentially expressed genes but not typical of any hybrid expression profiles or they were not differentially expressed neither between hybrids and parental lines nor between parental lines. The most prevalent profile of gene expression in hybrids was the intermediate one (24% of genes assigned to a hybrid expression profile). These results suggest that transcriptomic compatibility between S. haematobium and S. bovis remains quite high. We also found support for an over-dominance model (over- and under-expressed genes in hybrids compared to parental lines) potentially associated with heterosis. In females in particular, processes such as reproductive processes, metabolism and cell interactions as well as signaling pathways were indeed affected. Our study hence provides new insight on the biology of Schistosoma hybrids with evidences supporting compatibility and heterosis. Author summary: When two species, composed of different parental genetic material, manage to produce a viable offspring, new allelic interactions might arise. We do not know much about how genes are expressed in such hybrids compared to their parental species, especially for parasite species. Here we investigated gene expressions in first generation hybrids of two blood fluke parasites: Schistosoma haematobium and S. bovis. We quantified and assigned in five typical profiles genes expressed in first generation hybrids (i.e., intermediate between the parental expression levels, over-expressed, under-expressed, or expressed like one of the parental lines) and investigated their associated biological processes. Gene expressions in hybrids revealed a substantial fraction of genes being unassigned (once the sex and the direction of the cross from which a hybrid resulted were controlled) which were differentially expressed genes but not typical of any expression profiles or were not differentially expressed neither between hybrids and parental lines nor between parental lines. Among assigned genes, we recorded a predominance of genes being expressed at an intermediate level in hybrids compared to both parental species, hence highlighting the compatibility between the two species. Interestingly, we found, in particular in female hybrids, genes over- and under-expressed compared to parental lines. Those synergetic expression profiles are usually associated with heterosis in a model called over-dominance. At the functional level, our results provide evidence for compatibility between parental lines and potential heterosis in hybrids with biological processes expressed in hybrids involved in signaling pathways, energy intake, and reproduction. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. MyD88 Signaling Accompanied by Microbiota Changes Supports Urinary Bladder Carcinogenesis.
- Author
-
Knezović, Dora, Milić Roje, Blanka, Vilović, Katarina, Franković, Lucija, Korac-Prlic, Jelena, and Terzić, Janoš
- Subjects
- *
MYELOID differentiation factor 88 , *BACILLUS (Bacteria) , *BCG immunotherapy , *INTRAVESICAL administration , *SCHISTOSOMA haematobium , *BLADDER - Abstract
Urinary bladder cancer (BC) inflicts a significant impairment of life quality and poses a high mortality risk. Schistosoma haematobium infection can cause BC, and the urinary microbiota of BC patients differs from healthy controls. Importantly, intravesical instillation of the bacterium Bacillus Calmette-Guerin stands as the foremost therapy for non-muscle invasive BC. Hence, studying the receptors and signaling molecules orchestrating bacterial recognition and the cellular response in the context of BC is of paramount importance. Thus, we challenged Toll-like receptor 4 (Tlr4) and myeloid differentiation factor 88 (Myd88) knock-out (KO) mice with N-butyl-N-(4-hydroxylbutyl)-nitrosamine (BBN), a well-known urinary bladder carcinogen. Gut microbiota, gene expression, and urinary bladder pathology were followed. Acute exposure to BBN did not reveal a difference in bladder pathology despite differences in the animal's ability to recognize and react to bacteria. However, chronic treatment resulted in reduced cancer invasiveness among Myd88KO mice while the absence of functional Tlr4 did not influence BC development or progression. These differences correlate with a heightened abundance of the Faecalibaculum genus and the lowest microbial diversity observed among Myd88KO mice. The presented data underscore the important role of microbiota composition and MyD88-mediated signaling during bladder carcinogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Test-treat-track-test-treat (5T) approach for Schistosoma haematobium elimination on Pemba Island, Tanzania.
- Author
-
Trippler, Lydia, Taylor, Lyndsay, Ali, Mohammed Nassor, Najim, Sarah Omar, Khamis, Khamis Seif, Hattendorf, Jan, Juma, Saleh, Ame, Shaali Makame, Kabole, Fatma, Ali, Said Mohammed, and Knopp, Stefanie
- Subjects
- *
SCHISTOSOMA haematobium , *BODIES of water , *HEALTH facilities , *SCHISTOSOMIASIS , *DRUG administration - Abstract
Background: After decades of praziquantel mass drug administration (MDA), several countries approach schistosomiasis elimination. Continuing MDA in largely uninfected populations no longer seems justified. Alternative interventions to maintain the gains or accelerate interruption of transmission are needed. We report results, strengths, and shortcomings of novel test-treat-track-test-treat (5T) interventions in low Schistosoma haematobium prevalence areas on Pemba, Tanzania. Methods: School- and household-based surveys were conducted in 2021 and 2022 to monitor the S. haematobium and microhematuria prevalence and assess the impact of interventions. In 2021, 5T interventions were implemented in 15 low-prevalence areas and included: (i) testing schoolchildren in primary and Islamic schools for microhematuria as a proxy for S. haematobium, (ii) treating positive children, (iii) tracking them to their households and to water bodies they frequented, (iv) testing individuals at households and water bodies, and (v) treating positive individuals. Additionally, test-and-treat interventions were implemented in the 22 health facilities of the study area. Results: The S. haematobium prevalence in the school-based survey in 15 low-prevalence implementation units was 0.5% (7/1560) in 2021 and 0.4% (6/1645) in 2022. In the household-based survey, 0.5% (14/2975) and 0.7% (19/2920) of participants were infected with S. haematobium in 2021 and 2022, respectively. The microhematuria prevalence, excluding trace results, in the school-based survey was 1.4% (21/1560) in 2021 and 1.5% (24/1645) in 2022. In the household-based survey, it was 3.3% (98/2975) in 2021 and 5.4% (159/2920) in 2022. During the 5T interventions, the microhaematuria prevalence was 3.8% (140/3700) and 5.8% (34/594) in children in primary and Islamic schools, respectively, 17.1% (44/258) in household members, and 16.7% (10/60) in people at water bodies. In health facilities, 19.8% (70/354) of patients tested microhematuria-positive. Conclusions: The targeted 5T interventions maintained the very low S. haematobium prevalence and proved straightforward and feasible to identify and treat many of the few S. haematobium-infected individuals. Future research will show whether 5T interventions can maintain gains in the longer-term and expedite elimination. Trial registration: ISRCTN, ISCRCTN91431493. Registered 11 February 2020, https://www.isrctn.com/ISRCTN91431493. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Genetic diversity and population genetics of Schistosoma haematobium isolated from children in Lusaka and Siavonga districts, Zambia.
- Author
-
Tembo, Rabecca, Muleya, Walter, Zulu, Mildred, Mwaba, Florence, Monde, Ngula, Mukubesa, Andrew N., Ndebe, Joseph, Moonga, Ladslav, and Phiri, Andrew M.
- Abstract
Urogenital schistosomiasis remains a pervasive health challenge in rural Zambian communities. This study explores the molecular epidemiology and genetic diversity of Schistosoma haematobium using mitochondrial genes (cox1 and nadh1). Urine samples from 421 children in Siavonga and Lusaka districts, Zambia, were collected between December 2020 and February 2022. Microscopy and DNA extraction facilitated the identification of S. haematobium, followed by amplification, sequencing, and phylogenetic analysis of cox1 and nadh1 genes. Phylogenetic analysis revealed clustering with samples from mainland African countries, emphasizing shared haplotypes. Both mitochondrial genes exhibited substantial diversity, with 5 haplotypes from 37 cox1 sequences and 12 haplotypes from 23 nadh1 sequences. High haplotype diversity (0.621–0.808) and low nucleotide diversity (0.00181–0.03288) were observed. Siavonga and Lusaka districts shared the majority of S. haematobium haplotypes. Molecular variance and genetic differentiation analysis indicated variations within populations rather than between populations (cox1: -0.025, nadh1: 0.01646). These findings suggest a limited differentiation between S. haematobium populations in Siavonga and Lusaka, potentially indicating gene flow. Tajima's test revealed negative values, indicating a departure from neutrality, introduction of rare alleles, and recent population expansion. This study contributes essential insights into S. haematobium population genetics, crucial for effective urogenital schistosomiasis control in Zambia. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Prevalence and correlations of schistosomiasis mansoni and schistosomiasis haematobium among humans and intermediate snail hosts: a systematic review and meta-analysis
- Author
-
Xin-Yao Wang, Qin Li, Yin-Long Li, Su-Ying Guo, Shi-Zhu Li, Xiao-Nong Zhou, Jia-Gang Guo, Robert Bergquist, Saleh Juma, Jian-Feng Zhang, Kun Yang, and Jing Xu
- Subjects
Schistosoma mansoni ,Schistosoma haematobium ,Bulinus ,Biomphalaria ,Prevalence ,Correlation analysis ,Infectious and parasitic diseases ,RC109-216 ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background The control of schistosomiasis is particularly difficult in sub-Saharan Africa, which currently harbours 95% of this disease. The target population for preventive chemotherapy (PC) is expanded to all age group at risk of infection, thus increasing the demands of praziquantel (PZQ) tablets according to the new released guideline by World Health Organization. Due to the gap between available PZQ for PC and requirements, alternative approaches to assess endemicity of schistosomiasis in a community, are urgently needed for more quick and precise methods. We aimed to find out to which degree the infection status of snails can be used to guide chemotherapy against schistosomiasis. Methods We searched literature published from January 1991 to December 2022, that reported on the prevalence rates of Schistosoma mansoni, S. haematobium in the intermediate snails Biomphalaria spp. and Bulinus spp., respectively, and in humans. A random effect model for meta-analyses was used to calculate the pooled prevalence estimate (PPE), with heterogeneity assessed using I-squared statistic (I 2 ), with correlation and regression analysis for the exploration of the relationship between human S. mansoni and S. haematobium infections and that in their specific intermediate hosts. Results Forty-seven publications comprising 59 field investigations were included. The pooled PPE of schistosomiasis, schistosomiasis mansoni and schistosomiasis haematobium in humans were 27.5% [95% confidence interval (CI): 24.0–31.1%], 25.6% (95% CI: 19.9–31.3%), and 28.8% (95% CI: 23.4–34.3%), respectively. The snails showed an overall infection rate of 8.6% (95% CI: 7.7–9.4%), with 12.1% (95% CI: 9.9–14.2%) in the Biomphalaria spp. snails and 6.9% (95% CI: 5.7–8.1%) in the Bulinus spp. snails. The correlation coefficient was 0.3 (95% CI: 0.01–0.5%, P
- Published
- 2024
- Full Text
- View/download PDF
17. Detection of male genital schistosomiasis (MGS) associated with human, zoonotic and hybrid schistosomes in Southern Malawi
- Author
-
Sekeleghe Kayuni, Lucas Cunningham, Bright Mainga, Dingase Kumwenda, David Lally Jnr, Priscilla Chammudzi, Donales Kapira, Gladys Namacha, Alice Chisale, Tereza Nchembe, Louis Kinley, Ephraim Chibwana, Bessie Ntaba, Gilbert Chapweteka, Waleke Khumalo, Henry Chibowa, Victor Kumfunda, Alexandra Juhasz, Sam Jones, John Archer, Angus M. O’Ferrall, Sarah Rollason, John Chiphwanya, Peter Makaula, E. James LaCourse, Janelisa Musaya, and J. Russell Stothard
- Subjects
Lake Malawi ,Shire River ,Urogenital schistosomiasis ,Schistosoma haematobium ,Schistosoma mattheei ,Semen ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Male Genital Schistosomiasis (MGS) remains an often-overlooked chronic sequela of urogenital schistosomiasis in endemic areas of sub-Saharan Africa. As part of a 2-year longitudinal study on Hybridization of UroGenital Schistosomiasis (HUGS) in Malawi, a MGS sub-study was conducted to assess whether hybrid schistosomes were incriminated. Methods During recruitment, demographic, health and socio-economic data were collected through individual questionnaire interviews in Mthawira community from Nsanje District along Shire River and Samama community from Mangochi District along Lake Malawi shoreline. Urine and semen samples were collected and analysed to determine the identity of schistosome infection. Urine filtration and microscopy, direct microscopy of semen and its sediments (after centrifugation) were performed. Thereafter, the sediments were examined by molecular DNA analysis with a novel two-tube real-time PCR assay. The participants were also screened for Human papilloma virus (HPV) and other sexually transmitted infections (STIs). Results Twenty-two men were recruited for the sub-study, 8 in Nsanje District and 14 in Mangochi District, with a median age of 22.0 years. By microscopy, ten (45.7%) participants had Schistosoma ova in their urine, 11 (50.0%) in semen while 16 (72.7%) were positive by real-time PCR. One participant had both S. haematobium and S. mattheei ova in his semen, three showed symptoms, and one had a mixed infection of S. mansoni and possible S. haematobium-S. mattheei hybrid. Twelve men had detectable high-risk HPV serotypes 16, 18 and others while six had Trichomonas vaginalis and other STIs. Conclusion Zoonotic and hybrid schistosomes can cause MGS similar to human schistosomes, which can be co-infected with HPV and STIs, thereby posing a new challenge in diagnosis, management and control measures in resource poor settings. Increased awareness of these infections among local communities and primary healthcare workers and improvement of disease management are needed and advocated.
- Published
- 2024
- Full Text
- View/download PDF
18. Refining the Schistosoma haematobium recombinase polymerase amplification (Sh-RPA) assay: moving towards point-of-care use in endemic settings
- Author
-
Owain Donnelly, Silvia Mesquita, John Archer, Said M. Ali, Zikmund Bartonicek, Elena B. Lugli, and Bonnie L. Webster
- Subjects
Diagnostic ,Molecular ,Isothermal ,Point-of-care ,Schistosomiasis ,Schistosoma haematobium ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Urogenital schistosomiasis is caused by the parasitic trematode Schistosoma haematobium. Sensitive and specific point-of-care diagnostics are needed for elimination of this disease. Recombinase polymerase amplification (RPA) assays meet these criteria, and an assay to diagnose S. haematobium has been developed (Sh-RPA). However, false-positive results can occur, and optimisation of reaction conditions to mitigate these is needed. Ease of use and compatibility of DNA extraction methods must also be considered. Methods Using synthetic DNA, S. haematobium genomic DNA (gDNA), and urine samples from clinical cases, Sh-RPA reactions incorporating different betaine concentrations (0 M, 1 M, 2.5 M, 12.5 M) and the sample-to-water ratios were tested to determine effects on assay specificity and sensitivity. In addition, five commercial DNA extraction kits suitable for use in resource-limited settings were used to obtain gDNA from single S. haematobium eggs and evaluated in terms of DNA quality, quantity, and compatibility with the Sh-RPA assay. All samples were also evaluated by quantitative polymerase chain reaction (qPCR) to confirm DNA acquisition. Results The analytical sensitivity of the Sh-RPA with all betaine concentrations was ≥ 10 copies of the synthetic Dra1 standard and 0.1 pg of S. haematobium gDNA. The addition of betaine improved Sh-RPA assay specificity in all reaction conditions, and the addition of 2.5 M of betaine together with the maximal possible sample volume of 12.7 µl proved to be the optimum reaction conditions. DNA was successfully isolated from a single S. haematobium egg using all five commercial DNA extraction kits, but the Sh-RPA performance of these kits varied, with one proving to be incompatible with RPA reactions. Conclusions The addition of 2.5 M of betaine to Sh-RPA reactions improved reaction specificity whilst having no detrimental effect on sensitivity. This increases the robustness of the assay, advancing the feasibility of using the Sh-RPA assay in resource-limited settings. The testing of commercial extraction kits proved that crude, rapid, and simple methods are sufficient for obtaining DNA from single S. haematobium eggs, and that these extracts can be used with Sh-RPA in most cases. However, the observed incompatibility of specific kits with Sh-RPA highlights the need for each stage of a molecular diagnostic platform to be robustly tested prior to implementation. Graphical Abstract
- Published
- 2024
- Full Text
- View/download PDF
19. Prevalence and associated factors of schistosomiasis among pregnant women in northern Senegal
- Author
-
Coumba Nar Ndiour, Bruno Senghor, Ousmane Thiam, Souleymane Niang, Amélé Nyedzie Wotodjo, Babacar Thiendella Faye, Ndeye Amy Ndiaye, Omar Sow, Khadime Sylla, Magatte Ndiaye, Oumar Gaye, Babacar Faye, Cheikh Sokhna, Souleymane Doucouré, and Doudou Sow
- Subjects
Schistosoma haematobium ,Schistosoma mansoni ,Pregnant women ,qPCR ,Richard toll ,Senegal ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Schistosomiasis remains a public health concern worldwide. It is responsible for more than 240 million cases in 78 countries, 40 million of whom are women of childbearing age. In the Senegal River basin, both Schistosoma haematobium and Schistosoma mansoni are very prevalent in school-age children. However, there is a lack of information on the burden of schistosomiasis in pregnant women, which can cause complications in the pregnancy outcome. This study aimed to determine the prevalence and associated factors of schistosomiasis in pregnant women. Methods We conducted a prospective cross-sectional study of pregnant women attending antenatal clinics at the health center of the Senegalese Sugar Company and at the hospital of Richard Toll between August and December 2021. The urine and stool samples collected were examined using microscopy techniques and quantitative polymerase chain reaction (qPCR) to detect the presence of S. haematobium and S. mansoni. The urines were previously tested using urine reagent strips to detect hematuria and proteinuria. Socio-demographical, clinical, and diagnostically data were recorded by the midwife and the gynaecologist. The data were analyzed using a logistic regression model. Results Among the 298 women examined for the infection by microscopic, 65 (21.81%) were infected with urogenital schistosomiasis, 10 (3.36%) with intestinal schistosomiasis, and 4 (1.34%) were co-infected with both types of schistosomiasis. Out of the 288 samples tested by qPCR, 146 (48.99%) were positive for S. haematobium, 49 (35.51%) for S. mansoni and 22 (15.94%) for both species (co-infection). Pregnant women having microscopic haematuria and proteinuria were significantly more infected (p
- Published
- 2024
- Full Text
- View/download PDF
20. Geographical influence on morphometric variability of genetically 'pure' schistosoma haematobium eggs from sub-saharan migrants in Spain
- Author
-
Reguera-Gomez, Marta, Valero, Maria Adela, Artigas, Patricio, de Elias-Escribano, Alejandra, Fantozzi, Maria Cecilia, Luzon-Garcia, Maria Pilar, Salas-Coronas, Joaquin, Boissier, Jerome, Mas-Coma, Santiago, and Bargues, Maria Dolores
- Published
- 2023
21. Accuracy of three serological techniques for the diagnosis of imported schistosomiasis in real clinical practice: Not all in the same boat
- Author
-
Luzon-Garcia, Maria Pilar, Cabeza-Barrera, Maria Isabel, Lozano-Serrano, Ana Belen, Soriano-Perez, Manuel Jesus, Castillo-Fernandez, Nerea, Vazquez-Villegas, Jose, Borrego-Jimenez, Jaime, and Salas-Coronas, Joaquin
- Published
- 2023
22. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial
- Author
-
Charles O. Obonyo, Fredrick O. Rawago, Nicholas K. Makworo, and Erick M. O. Muok
- Subjects
Schistosomiasis ,Praziquantel ,Artesunate plus sulfalene-pyrimethamine ,Artemisinin-based combinations ,Schistosoma mansoni ,Schistosoma haematobium ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Reliance on praziquantel for the treatment and control of schistosomiasis is likely to facilitate the emergence of drug resistance. Combination therapy targeting adult and juvenile schistosome worms is urgently needed to improve praziquantel efficacy and delay the potential development of drug resistance. We assessed the efficacy and safety of single-dose praziquantel combined with single-dose artesunate plus sulfalene-pyrimethamine in the treatment of Kenyan children with schistosomiasis. Methods This was an open-label, randomised clinical trial involving 426 school-aged children (7–15 years old) diagnosed with Schistosoma mansoni (by Kato-Katz) or S. haematobium (by urine filtration). They were randomly assigned (1:1:1) to receive a single dose of praziquantel (40 mg/kg), a single dose of artesunate plus sulfalene-pyrimethamine (12 mg/kg artesunate) or combination therapy using a single dose of praziquantel (40 mg/kg) combined with a single dose of artesunate plus sulfalene-pyrimethamine (12 mg/kg artesunate). The primary outcome was cure and egg reduction rates at 6 weeks post-treatment in the available case population. Adverse events were assessed within 3 h after treatment. Results Of the 426 children enrolled, 135 received praziquantel, 150 received artesunate plus sulfalene-pyrimethamine, and 141 received combination therapy. Outcome data were available for 348 (81.7%) children. For S. mansoni-infected children (n = 335), the cure rates were 75.6%, 60.7%, and 77.8%, and the egg reduction rates were 80.1%, 85.0%, and 88.4% for praziquantel, artesunate plus sulfalene-pyrimethamine, and combination therapy, respectively. For S. haematobium-infected children (n = 145), the corresponding cure rates were 81.4%, 71.1%, and 82.2%, and the egg reduction rates were 95.6%, 97.1%, and 97.7%, respectively. Seventy-one (16.7%) children reported mild-intensity adverse events. The drugs were well tolerated and no serious adverse events were reported. Conclusions A single oral dose of praziquantel combined with artesunate plus sulfalene-pyrimethamine cured a high proportion of children with S. haematobium but did not significantly improve the treatment efficacy for either urinary or intestinal schistosomiasis. Sequential administration of praziquantel and artesunate plus sulfalene-pyrimethamine may enhance the efficacy and safety outcomes. Graphical abstract
- Published
- 2024
- Full Text
- View/download PDF
23. Strategies and achievements in controlling and eliminating schistosomiasis from Egypt
- Author
-
Mohamed El-Kassas, Reem El Sheemy, and Mohamed Elbadry
- Subjects
Control ,Egypt ,Elimination ,Schistosomiasis ,Schistosoma haematobium ,Schistosoma mansoni ,Surgery ,RD1-811 ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Abstract Schistosomiasis is an old parasitic disease in Egypt primarily caused by Schistosoma mansoni, transmitted through infected water canals, and disproportionately affects rural areas. Despite substantial reductions in the disease prevalence over the years, it still affects more than 5% of the population in some governorates, highlighting the need for sustained control efforts. Among the recent control measures: (a) mass drug administration with large-scale, biannual administration of praziquantel, which remains the cornerstone of the control program targeting the interruption of vector transmission cycles. (b) Improving disease diagnostics, including point-of-care tests, which facilitate early detection and case management, particularly in remote areas. (c) Snail control using targeted mollusciciding aims to reduce parasite transmission by controlling intermediate snail hosts. And (d) behavioral change communication focusing on raising awareness regarding hygiene practices and safe water access. Even if control attempts have shown positive results, several challenges still exist, including (a) drug resistance, especially to praziquantel, the most commonly used drug, which calls for ongoing observation and monitoring. (b) Sustainability of funding to avoid program disruptions and setbacks. And (c) social and environmental factors like poverty, poor sanitation, and access to clean water. The transition from disease control to elimination requires meticulous planning and vigilance. Robust surveillance systems, enhanced case management, and continued community engagement are vital for such elimination. Strengthening research on drug resistance, snail control methods, and innovative diagnostics would further support elimination efforts. This report aims to address the most recent data regarding the prevalence and control measures for schistosomiasis in Egypt and provide the information required to lead the transition from disease control to elimination.
- Published
- 2024
- Full Text
- View/download PDF
24. Impact of helminth infections during pregnancy on maternal and newborn Vitamin D and on birth outcomes.
- Author
-
Berry, Sèyigbéna P. Déo-Gracias, Honkpèhedji, Yabo Josiane, Ludwig, Esther, Mahmoudou, Saïdou, Prodjinotho, Ulrich Fabien, Adamou, Rafiou, Nouatin, Odilon P., Adégbitè, Bayode R., Dejon-Agobe, Jean Claude, Mba, Romuald Beh, Maloum, Moustapha, Nkoma, Anne Marie Mouima, Zinsou, Jeannot Fréjus, Luty, Adrian J. F., Esen, Meral, Adégnika, Ayôla Akim, and Prazeres da Costa, Clarissa
- Subjects
- *
HELMINTHIASIS , *MIDDLE-income countries , *VITAMIN D deficiency , *SCHISTOSOMA haematobium , *NEWBORN infants , *VITAMIN D , *PREGNANCY - Abstract
Poor birth outcomes in low- and middle income countries are associated with maternal vitamin D deficiency and chronic helminth infections. Here, we investigated whether maternal Schistosoma haematobium affects maternal or cord vitamin D status as well as birth outcomes. In a prospective cross-sectional study of pregnant women conducted in Lambaréné, Gabon, we diagnosed maternal parasitic infections in blood, urine and stool. At delivery we measured vitamin D in maternal and cord blood. S. haematobium, soil-transmitted helminths, and microfilariae were found at prevalences of 30.2%, 13.0%, and 8.8%, respectively. Insufficient vitamin D and calcium levels were found in 28% and 15% of mothers, and in 11.5% and 1.5% of newborns. Mothers with adequate vitamin D had lower risk of low birthweight babies (aOR = 0.11, 95% CI 0.02–0.52, p = 0.01), whilst offspring of primipars had low cord vitamin D levels, and low vitamin D levels increased the risk of maternal inflammation. Maternal filariasis was associated with low calcium levels, but other helminth infections affected neither vitamin D nor calcium levels in either mothers or newborns. Healthy birth outcomes require maintenance of adequate vitamin D and calcium levels. Chronic maternal helminth infections do not disrupt those levels in a semi-rural setting in sub-Saharan Africa. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.
- Author
-
Obonyo, Charles O., Rawago, Fredrick O., Makworo, Nicholas K., and Muok, Erick M. O.
- Subjects
- *
SCHISTOSOMA mansoni , *SCHISTOSOMA haematobium , *PRAZIQUANTEL , *SCHOOL children , *KENYANS - Abstract
Background: Reliance on praziquantel for the treatment and control of schistosomiasis is likely to facilitate the emergence of drug resistance. Combination therapy targeting adult and juvenile schistosome worms is urgently needed to improve praziquantel efficacy and delay the potential development of drug resistance. We assessed the efficacy and safety of single-dose praziquantel combined with single-dose artesunate plus sulfalene-pyrimethamine in the treatment of Kenyan children with schistosomiasis. Methods: This was an open-label, randomised clinical trial involving 426 school-aged children (7–15 years old) diagnosed with Schistosoma mansoni (by Kato-Katz) or S. haematobium (by urine filtration). They were randomly assigned (1:1:1) to receive a single dose of praziquantel (40 mg/kg), a single dose of artesunate plus sulfalene-pyrimethamine (12 mg/kg artesunate) or combination therapy using a single dose of praziquantel (40 mg/kg) combined with a single dose of artesunate plus sulfalene-pyrimethamine (12 mg/kg artesunate). The primary outcome was cure and egg reduction rates at 6 weeks post-treatment in the available case population. Adverse events were assessed within 3 h after treatment. Results: Of the 426 children enrolled, 135 received praziquantel, 150 received artesunate plus sulfalene-pyrimethamine, and 141 received combination therapy. Outcome data were available for 348 (81.7%) children. For S. mansoni-infected children (n = 335), the cure rates were 75.6%, 60.7%, and 77.8%, and the egg reduction rates were 80.1%, 85.0%, and 88.4% for praziquantel, artesunate plus sulfalene-pyrimethamine, and combination therapy, respectively. For S. haematobium-infected children (n = 145), the corresponding cure rates were 81.4%, 71.1%, and 82.2%, and the egg reduction rates were 95.6%, 97.1%, and 97.7%, respectively. Seventy-one (16.7%) children reported mild-intensity adverse events. The drugs were well tolerated and no serious adverse events were reported. Conclusions: A single oral dose of praziquantel combined with artesunate plus sulfalene-pyrimethamine cured a high proportion of children with S. haematobium but did not significantly improve the treatment efficacy for either urinary or intestinal schistosomiasis. Sequential administration of praziquantel and artesunate plus sulfalene-pyrimethamine may enhance the efficacy and safety outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Capacities and needs of health care facilities for schistosomiasis diagnosis and management in elimination settings.
- Author
-
Ndum, Naomi C., Trippler, Lydia, Mohammed, Ulfat A., Ali, Anisa S., Hattendorf, Jan, Utzinger, Jürg, Ali, Said M., and Knopp, Stefanie
- Subjects
- *
HEALTH facilities , *SCHISTOSOMIASIS , *SCHISTOSOMA haematobium , *ENDEMIC diseases , *DIAGNOSIS - Abstract
Background: Schistosomiasis is a debilitating neglected tropical disease endemic in sub-Saharan Africa. The role of health facilities in the prevention, diagnosis, control, and elimination of schistosomiasis is poorly documented. In a setting targeted for schistosomiasis elimination in Zanzibar, we assessed the prevalence of Schistosoma haematobium among patients seeking care in a health facility and investigated schistosomiasis-related knowledge of staff, and health facilities' capacities and needs for schistosomiasis diagnosis and management. Methods: We conducted a health facility-based mixed-method study on Pemba Island from June to August 2023. Patients aged ≥ 4 years seeking care in four health facilities were screened for S. haematobium infection using urine filtration and reagent strips. Those patients aged ≥ 10 years were additionally interviewed about signs and symptoms. Staff from 23 health facilities responded to a questionnaire assessing knowledge and practices. Ten staff participated in a focus group discussion (FGD) about capacities and needs for schistosomiasis diagnosis and management. Results: The prevalence of S. haematobium infection in patients attending the health facilities, as determined by the presence of eggs in urine, was 1.1% (8/712). Microhaematuria was detected in 13.3% (95/712) of the patients using reagent strips. Among patients responding to the questionnaire, pelvic pain, pain during sex, and painful urination were reported by 38.0% (237/623), 6.3% (39/623), and 3.2% (20/623), respectively. Among the health facility staff, 90.0% (44/49) and 87.8% (43/49) identified blood in urine and pelvic pain, respectively, as symptoms of urogenital schistosomiasis, 81.6% (40/49) and 93.9% (46/49) reported collecting a urine sample and pursuing a reagent strip test, respectively, for diagnosis, and 87.8% (43/49) administered praziquantel for treatment. The most reoccurring themes in the FGD were the need for more staff training about schistosomiasis, requests for diagnostic equipment, and the need to improve community response to schistosomiasis services in health facilities. Conclusions: The prevalence of S. haematobium infection in patients seeking care in health facilities in Pemba is very low and similar to what has been reported from recent community-based cross-sectional surveys. The health facility staff had good schistosomiasis-related knowledge and practices. However, to integrate schistosomiasis patient management more durably into routine health facility activities, scalable screening pathways need to be identified and capacities need to be improved by regular staff training, and an unbroken supply of accurate point-of-care diagnostics and praziquantel for the treatment of cases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Pediatric urogenital schistosomiasis diagnosed in France.
- Author
-
Percheron, Lucas, Leblanc, Claire, Ulinski, Tim, Fila, Marc, Malvy, Denis, Bacchetta, Justine, Guigonis, Vincent, Debuisson, Cecile, Launay, Elise, Martinez, Edouard, Morand, Aurelie, Decramer, Stéphane, Schanstra, Joost-Peter, and Berry, Antoine
- Subjects
- *
SCHISTOSOMIASIS diagnosis , *GENITOURINARY disease diagnosis , *DISEASES in men , *URINARY tract infections , *NOMADS , *SYMPTOMS , *CHILDREN'S hospitals , *DESCRIPTIVE statistics , *HEMATURIA , *CHRONIC kidney failure , *PEDIATRICS , *ISOQUINOLINE , *SCHISTOSOMIASIS , *ANTHELMINTICS , *CHILDREN - Abstract
Background: Schistosomiasis affects approximately 230 million people worldwide. There is an increased incidence of schistosomiasis cases in France acquired from outside the country. This increases the risk of schistosomiasis outbreaks as observed in Corsica. Clinicians from non-endemic regions are not accustomed to diagnosing and managing this pathology. The objective of this study is to provide a better description of the clinical and paraclinical characteristics and disease evolution of affected children. Methods: Through the French Pediatric Nephrology Society and the Pediatric Infectious Pathology Group, we contacted all French pediatric centers that may have treated children with urinary schistosomiasis between 2013 and 2019. Age, sex, comorbidities, and clinical, biological, and radiological data (at discovery and follow-up) were collected retrospectively. Results: A total of 122 patients from 10 different centers were included. The median age was 14 years and the sex ratio M/F was 4:1. Hematuria was present in 82% of the patients while urinary tract abnormality was found in 36% of them. Fourteen patients (11%) displayed complicated forms of urinary schistosomiasis including 10 patients with chronic kidney disease. A total of 110 patients received treatment with praziquantel, which was well-tolerated and led to clinical resolution of symptoms in 98% of cases. Conclusion: Patients with schistosomiasis present frequent kidney, urinary, or genital involvement. Systematic screening of patients returning from endemic areas is therefore recommended, especially since treatment with antiparasitic drugs is effective and well-tolerated. Enhancing medical knowledge of this pathology among all practitioners is essential to improve care and outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Immunochromatography Lateral Flow Strip Enhancement Based on Passive Gold Nanoparticles Conjugation to Detect Schistosma haematobium Antigens in Human Serum.
- Author
-
El-Shall, Mahmoud N., Aly, Ibrahim, Samen, Alaa, Salama, Wesam M., and Baakdah, Fadi
- Subjects
GOLD nanoparticles ,SCHISTOSOMA haematobium ,ENZYME-linked immunosorbent assay ,ANTIGENS ,POTASSIUM carbonate ,IMMUNOGLOBULINS ,SERUM - Abstract
Purpose: This study aimed to develop and evaluate a lateral flow card for the detection of active Schistosoma haematobium infection. Methods: In order to prepare the immunochromatography lateral flow strip (ICLFS), antibodies purified from schistosomiasis were conjugated passively with gold nanoparticles using a potassium carbonate buffer. Results: The novel ICLFS was able to correctly identify 64 out of 67 samples of schistosomiasis, 6 out of 90 samples of other parasites, and 0 out of 27 control samples. Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were 95.5%, 93.3%, 90%, and 91.4% respectively. Comparatively, the sensitivity, specificity, NPV, and PPV of sandwich enzyme-linked immunosorbent assays (ELISA) conjugated with gold nanoparticles (AuNPs) were 91.1%, 88.8%, 85.9%, and 84.4% respectively. The increased sensitivity and specificity of ICLFS produced superior results to those of sandwich ELISA. Conclusion: In conclusion, ICLFS is more beneficial and precise than sandwich ELISA for detection of S. haematobium infection at early stage. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Next step towards point-of-care molecular diagnosis of female genital schistosomiasis (FGS): evaluation of an instrument-free LAMP procedure.
- Author
-
van Bergen, Kim J. M., Brienen, Eric A. T., Randrianasolo, Bodo S., Ramarokoto, Charles E., Leutscher, Peter, Kjetland, Eyrun F., van Diepen, Angela, Dekker, Floris, Saggiomo, Vittorio, Velders, Aldrik H., and van Lieshout, Lisette
- Abstract
Detection of Schistosoma spp. DNA in gynaecological samples by quantitative real-time polymerase chain reaction (qPCR) is considered to be the reference diagnostic test for female genital schistosomiasis (FGS). However, qPCR needs expensive laboratory procedures and highly trained technicians. Loop-mediated amplification (LAMP) is a more field-friendly isothermal procedure for the detection of parasite-specific DNA, but it still requires electrically powered equipment. Here, we validated a Schistosoma haematobium-specific Sh-LAMP procedure and tested a fully instrument-free isothermal amplification using a novel low-cost, and reusable Temperature-cup (T-cup) device. Specific primers were selected based on published assays, targeting the ribosomal intergenic spacer (IGS) region of S. haematobium. Technical validation of the IGS-Sh-LAMP was performed using 20 negative controls, including DNA extracts of soil-transmitted helminths and S. mansoni, and a 10-fold dilution series (100-10-3) of DNA extracted from a single S. haematobium egg (n=4). For clinical validation, the IGS-Sh-LAMP was tested on 125 DNA samples extracted from vaginal swabs of a previous FGS study in Madagascar. Results were compared with the quantification cycle value (Cq) of the standard ITS-2 targeting qPCR. Single S. haematobium egg DNA up to a 10-2 dilution and an ITS-2 Cq <35 tested positive in the IGS-Sh-LAMP. The specificity was found to be excellent (100%). In the clinical samples, IGS-Sh-LAMP showed comparable results with the qPCR, with 35.2% and 33.6% positives, respectively, and a concordance of 79.2% (99/125). Of the 12 false-negatives, 5 corresponded to the 7 qPCR positive samples with very low DNA levels (Cq ≥35). On the other hand, IGS-Sh-LAMP detected 14 additional cases that were not detected by qPCR. The T-cup IGS-Sh-LAMP performance was evaluated in a representative sub-selection (n=10) of IGS-Sh-LAMP positive clinical samples. The T-cup IGS-Sh-LAMP was found to be a very user-friendly method, but in different runs, it missed 1 to 4 of the 10 IGS-Sh-LAMP positive samples, specifically those with a low DNA load. Our results show that the IGSSh-LAMP is a suitable alternative to the ITS-2 qPCR for the diagnosis of FGS in gynaecological samples, with high potential for the T-cup as a fully instrumentfree isothermal amplification device for point-of-care diagnosis in lowresource settings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Evaluating the Performance of FlukeCatcher at Detecting Urogenital Schistosomiasis.
- Author
-
Fok, Louis, Erko, Berhanu, Brett-Major, David, Animut, Abebe, Broadhurst, M. Jana, Dai, Daisy, Linville, John, Levecke, Bruno, Negash, Yohannes, and Degarege, Abraham
- Subjects
- *
SCHISTOSOMIASIS , *SCHISTOSOMA haematobium , *TEST methods , *URINE , *EGGS - Abstract
Urine filtration microscopy (UFM) lacks sensitivity in detecting low-intensity Schistosoma haematobium infections. In pursuit of a superior alternative, this study evaluated the performance of FlukeCatcher microscopy (FCM) at detecting S. haematobium eggs in human urine samples. Urine samples were collected from 572 school-age children in Afar, Ethiopia in July 2023 and examined using UFM and FCM approaches. Using the combined UFM and FCM results as a reference, the sensitivity, negative predictive value, and agreement levels for the two testing methods in detecting S. haematobium eggs in urine samples were calculated. The sensitivity and negative predictive value of detecting S. haematobium eggs in urine samples for FCM was 84% and 97%, respectively, compared to 65% and 93% for UFM. The FCM test results had an agreement of 61% with the UFM results, compared to 90% with the combined results of FCM and UFM. However, the average egg count estimates were lower when using FCM (6.6 eggs per 10 mL) compared to UFM (14.7 eggs per 10 mL) (p < 0.0001). Incorporating FCM into specimen processing could improve the diagnosis of S. haematobium infection but may underperform in characterizing the intensity of infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Accelerating snail vector genomics.
- Author
-
Pennance, Tom and Rollinson, David
- Subjects
- *
SNAILS , *SCHISTOSOMA japonicum , *SCHISTOSOMA haematobium , *GENOMICS , *BIOMPHALARIA - Abstract
The three most important genera of snails for the transmission of schistosomes are Bulinus, Biomphalaria and Oncomelania. Each of these genera, found in two distantly related families, includes species that act as the intermediate host for one of the three most widespread schistosome species infecting humans, Schistosoma haematobium, S. mansoni and S. japonicum, respectively. An important step in the fight against schistosomiasis in Asia has been taken with the publication of the article "Chromosome-level genome assembly of Oncomelania hupensis: the intermediate snail host of Schistosoma japonicum", which means that genomes for all three major genera, including species across three continents, are now available in the public domain. This includes the first genomes of African snail vectors, namely Biomphalaria sudanica, Bi. pfeifferi and Bulinus truncatus, as well as high-quality chromosome level assemblies for South American Bi. glabrata. Most importantly, the wealth of new genomic and transcriptomic data is helping to establish the specific molecular mechanisms that underly compatibility between snails and their schistosomes, which although diverse and complex, may help to identify potential targets dictating host parasite interactions that can be utilised in future transmission control strategies. This new work on Oncomelania hupensis and indeed studies on other snail vectors, which provide deep insights into the genome, will stimulate research that may well lead to new and much needed control interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Female genital schistosomiasis burden and risk factors in two endemic areas in Malawi nested in the Morbidity Operational Research for Bilharziasis Implementation Decisions (MORBID) cross-sectional study.
- Author
-
Lamberti, Olimpia, Kayuni, Sekeleghe, Kumwenda, Dingase, Ngwira, Bagrey, Singh, Varsha, Moktali, Veena, Dhanani, Neerav, Wessels, Els, Van Lieshout, Lisette, Fleming, Fiona M., Mzilahowa, Themba, and Bustinduy, Amaya L.
- Subjects
- *
OPERATIONS research , *SCHISTOSOMIASIS , *RESEARCH implementation , *SCHISTOSOMA haematobium , *MEDICAL screening , *GENITALIA infections - Abstract
Background: Female genital schistosomiasis (FGS), caused by the parasite Schistosoma haematobium (Sh), is prevalent in Sub-Saharan Africa. FGS is associated with sexual dysfunction and reproductive morbidity, and increased prevalence of HIV and cervical precancerous lesions. Lack of approved guidelines for FGS screening and diagnosis hinder accurate disease burden estimation. This study evaluated FGS burden in two Sh-endemic areas in Southern Malawi by visual and molecular diagnostic methods. Methodology/Principal findings: Women aged 15–65, sexually active, not menstruating, or pregnant, were enrolled from the MORBID study. A midwife completed a questionnaire, obtained cervicovaginal swab and lavage, and assessed FGS-associated genital lesions using hand-held colposcopy. 'Visual-FGS' was defined as specific genital lesions. 'Molecular-FGS' was defined as Sh DNA detected by real-time PCR from swabs. Microscopy detected urinary Sh egg-patent infection. In total, 950 women completed the questionnaire (median age 27, [IQR] 20–38). Visual-and molecular-FGS prevalence were 26·9% (260/967) and 8·2% (78/942), respectively. 6·5% of women with available genital and urinary samples (38/584) had egg-patent Sh infection. There was a positive significant association between molecular- and visual-FGS (AOR = 2·9, 95%CI 1·7–5·0). 'Molecular-FGS' was associated with egg-patent Sh infection (AOR = 7·5, 95% CI 3·27–17·2). Some villages had high 'molecular-FGS' prevalence, despite <10% prevalence of urinary Sh among school-age children. Conclusions/Significance: Southern Malawi carries an under-recognized FGS burden. FGS was detectable in villages not eligible for schistosomiasis control strategies, potentially leaving girls and women untreated under current WHO guidelines. Validated field-deployable methods could be considered for new control strategies. Author summary: Female genital schistosomiasis (FGS) is a neglected gynaecological disease caused by the waterborne parasite Schistosoma (S.) haematobium. Despite over 45 million women are at risk of FGS in sub-Sahara Africa (SSA), approximately only 15,000 have been screened for the disease. Diagnosis is challenging and has traditionally required high technical expertise based on visual inspection for FGS typical lesions of the genital tract using a standard colposcope, seldom available in endemic settings. Closer-to the-user and decentralized strategies for FGS screening and diagnosis should be implemented to assess disease burden and scale-up FGS surveillance. This study was nested within the larger Morbidity Operational Research for Bilharziasis Implementation Decision (MORBID) cross-sectional project, aiming to correlate schistosomiasis-related morbidity data with village level endemicity across two districts in Southern Malawi. We found a significantly moderate to high burden of FGS (between 8–27% depending on diagnostic method used), with marked age differences in diagnostic performance. Further, some villages with low schistosomiasis prevalence (which would be excluded from control strategies per new WHO guidelines), had a significantly high burden of FGS, indicating the need for formal public health interventions. Within the remit of the sustainable development goals, this study's approach and findings emphasize the need of a field-deployable strategy to FGS screening and diagnosis in endemic areas in Malawi and other similar setting. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Strategies and achievements in controlling and eliminating schistosomiasis from Egypt.
- Author
-
El-Kassas, Mohamed, Sheemy, Reem El, and Elbadry, Mohamed
- Subjects
- *
SCHISTOSOMIASIS , *SCHISTOSOMA mansoni , *PARASITIC diseases , *CONSCIOUSNESS raising , *DISEASE eradication - Abstract
Schistosomiasis is an old parasitic disease in Egypt primarily caused by Schistosoma mansoni, transmitted through infected water canals, and disproportionately affects rural areas. Despite substantial reductions in the disease prevalence over the years, it still affects more than 5% of the population in some governorates, highlighting the need for sustained control efforts. Among the recent control measures: (a) mass drug administration with large-scale, biannual administration of praziquantel, which remains the cornerstone of the control program targeting the interruption of vector transmission cycles. (b) Improving disease diagnostics, including point-of-care tests, which facilitate early detection and case management, particularly in remote areas. (c) Snail control using targeted mollusciciding aims to reduce parasite transmission by controlling intermediate snail hosts. And (d) behavioral change communication focusing on raising awareness regarding hygiene practices and safe water access. Even if control attempts have shown positive results, several challenges still exist, including (a) drug resistance, especially to praziquantel, the most commonly used drug, which calls for ongoing observation and monitoring. (b) Sustainability of funding to avoid program disruptions and setbacks. And (c) social and environmental factors like poverty, poor sanitation, and access to clean water. The transition from disease control to elimination requires meticulous planning and vigilance. Robust surveillance systems, enhanced case management, and continued community engagement are vital for such elimination. Strengthening research on drug resistance, snail control methods, and innovative diagnostics would further support elimination efforts. This report aims to address the most recent data regarding the prevalence and control measures for schistosomiasis in Egypt and provide the information required to lead the transition from disease control to elimination. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Endemic status of urogenital schistosomiasis and the efficacy of a single-dose praziquantel treatment in unmapped rural farming communities in Oyo East Local Government Area, Oyo State, Nigeria.
- Author
-
Odaibo, Alexander B., Komolafe, Adenike K., Olajumoke, Taiwo O., Diyan, Kanyinsola D., Aluko, Damilare A., Alagbe, Oluwatunmininu A., Ajagbe, Oluwafemi A., and Olarinloye, David B.
- Subjects
- *
AGRICULTURE , *SCHISTOSOMIASIS , *BIOTIC communities , *SCHISTOSOMA haematobium , *SCHOOL children - Abstract
Background: Schistosomiasis is endemic in Nigeria, and the treatment is largely concentrated on children enrolled in schools. Consequently, the coverage of non-enrolled school-aged children is often neglected. Ajagba and Awosan are two communities in Nigeria that have never had any control intervention. Hence, this survey was designed to determine the endemicity of urogenital schistosomiasis and to evaluate the efficacy of a single-dose praziquantel in the communities. Methods: Urine sample (10 mL) of each participant from Ajagba and Awosan communities was filtered through 12μm polycarbonate filter. The filter was placed on a microscope slide, and stained with a drop of 1% Lugol iodine solution. The stained slides were examined under the microscope and the numbers of S. haematobium eggs were counted. Water contact sites were searched for snail hosts and the snails collected were shed for Schistosoma cercariae. Data were analyzed using SPSS version 24.0 and the significance level was set at 95%. Results: The overall prevalence of infection in the Ajagba community was 45.6% with a mean intensity of 61.1 ± 144.5 eggs/10 mL of urine, while the prevalence of infection in the Awosan community was 5.7% with a mean intensity of 1.4 ± 6.8 eggs/10 mL of urine. The school-aged children had a prevalence and mean intensity of infection of 73.1% and 111.6 ± 177.9 eggs/10 mL of urine, respectively. Following treatment, women had a higher egg reduction rate than men (p = 0.0283). Bulinus globosus were found in Ajagba but not in Awosan, with 5.7% shedding Schistosoma spp, cercariae. Conclusion: Urogenital schistosomiasis was hyperendemic in the Ajagba community, and hypoendemic in the Awosan community. The presence of Bulinus globosus supported the transmission of the schistosomiasis in the Ajagba community. Communities where schistosomiasis is still actively transmitted in Nigeria should be identified for effective intervention through the MDA programs. Author summary: Schistosoma haematobium causes urogenital schistosomiasis that is endemic and widely distributed in Nigeria. For effective control strategies, it is important to continue to identify and classify communities where the disease is still been transmitted. A cross-sectional community-based survey was conducted in two closely located rural farming communities that had not had any control interventions, to determine the status of the disease in the communities, and initiate the administration of medicine. Urine samples were collected from volunteering participants and examined for S. haematobium eggs. Of 167 participants who submitted urine samples in the two communities, 32.9% were infected. The Ajagba community had more infected participants (45.6%) than the Awosan community (5.7%). All age groups were infected in the Ajagba community, but school-aged children were more infected than any other age group. Snail intermediate hosts were found at the water contact site in Ajagba but not at water contact site in Awosan. The study suggests that communities with natural freshwater bodies that harbor appropriate snail intermediate hosts are at greater risk of infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Extant interspecific hybridization among trematodes within the Schistosoma haematobium species complex in Nigeria.
- Author
-
Ajakaye, Oluwaremilekun G., Enabulele, Elisha E., Balogun, Joshua B., Oyeyemi, Oyetunde T., and Grigg, Michael E.
- Subjects
- *
SCHISTOSOMA haematobium , *INTROGRESSION (Genetics) , *HUMAN-animal relationships , *SPECIES hybridization , *MITOCHONDRIAL DNA , *TREMATODA , *HYBRID zones - Abstract
Background: Natural interspecific hybridization between the human parasite (Schistosoma haematobium [Sh]) and bovine parasites (Schistosoma bovis [Sb], Schistosoma curassoni [Sc]) is increasingly reported in Africa. We developed a multi-locus PCR DNA-Seq strategy that amplifies two unlinked nuclear (transITS, BF) and two linked organellar genome markers (CO1, ND5) to genotype S. haematobium eggs collected from infected people in Ile Oluji/Oke Igbo, Ondo State (an agrarian community) and Kachi, Jigawa State (a pastoral community) in Southwestern and Northern Nigeria, respectively. Principal findings: Out of a total of 219 urine samples collected, 57 were positive for schistosomes. All patients from Jigawa state possessed an Sh mitochondrial genome and were infected with a genetic profile consistent with an Sh x Sb hybrid based on sequences obtained at CO1, ND5, transITS and BF nuclear markers. Whereas samples collected from Ondo state were more varied. Mitonuclear discordance was observed in all 17 patients, worms possessed an Sb mitochondrial genome but one of four different genetic profiles at the nuclear markers, either admixed (heterozygous between Sh x Sc or Sh x Sb) at both markers (n = 10), Sh at BF and admixed at transITS (Sh x Sc) (n = 5), admixed (Sh x Sc) at BF and homozygous Sc at transITS (n = 1) or homozygous Sh at BF and homozygous Sc at transITS (n = 1). Significance: Previous work suggested that zoonotic transmission of S. bovis in pastoral communities, where humans and animals share a common water source, is a driving factor facilitating interspecific hybridization. However, our data showed that all samples were hybrids, with greater diversity identified in Southwestern Nigeria, a non-pastoral site. Further, one patient possessed an S. bovis mitochondrial genome but was homozygous for S. haematobium at BF and homozygous for S. curassoni at transITS supporting at least two separate backcrosses in its origin, suggesting that interspecific hybridization may be an ongoing process. Author summary: Interspecific hybridization between trematode parasites pose serious health risks to humans. Many systems have shown possible hybridization between different schistosome species. As evidence of natural hybridization between human S. haematobium and animal S. bovis or S. curassoni has grown in recent years, epidemiological surveys across potential hybrid zones are required, particularly in endemic African regions. According to several reports, indiscriminate human-animal water contact is a major factor contributing to hybridization of human and animal schistosomes. We collected and genotyped 57 samples from pastoral and non-pastoral communities in Kachi, Jigawa state, and Ile Oluji/Oke Igbo, Ondo state, Nigeria to screen for hybrids. In both sites, we found Schistosoma hybrids with mitonuclear discordance that supported repeated backcrossing between S. haematobium, S. bovis, and S. curassoni. Contrary to previous reports, Schistosoma hybrids appear to be widespread and not solely dependent on human-animal water interactions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. An automated slide scanning system for membrane filter imaging in diagnosis of urogenital schistosomiasis.
- Author
-
Oyibo, Prosper, Agbana, Tope, van Lieshout, Lisette, Oyibo, Wellington, Diehl, Jan‐Carel, and Vdovine, Gleb
- Subjects
- *
MEMBRANE filters , *SCANNING systems , *SCHISTOSOMIASIS , *SCHISTOSOMA haematobium , *MICROSCOPES - Abstract
Traditionally, automated slide scanning involves capturing a rectangular grid of field‐of‐view (FoV) images which can be stitched together to create whole slide images, while the autofocusing algorithm captures a focal stack of images to determine the best in‐focus image. However, these methods can be time‐consuming due to the need for X‐, Y‐ and Z‐axis movements of the digital microscope while capturing multiple FoV images. In this paper, we propose a solution to minimise these redundancies by presenting an optimal procedure for automated slide scanning of circular membrane filters on a glass slide. We achieve this by following an optimal path in the sample plane, ensuring that only FoVs overlapping the filter membrane are captured. To capture the best in‐focus FoV image, we utilise a hill‐climbing approach that tracks the peak of the mean of Gaussian gradient of the captured FoVs images along the Z‐axis. We implemented this procedure to optimise the efficiency of the Schistoscope, an automated digital microscope developed to diagnose urogenital schistosomiasis by imaging Schistosoma haematobium eggs on 13 or 25 mm membrane filters. Our improved method reduces the automated slide scanning time by 63.18% and 72.52% for the respective filter sizes. This advancement greatly supports the practicality of the Schistoscope in large‐scale schistosomiasis monitoring and evaluation programs in endemic regions. This will save time, resources and also accelerate generation of data that is critical in achieving the targets for schistosomiasis elimination. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Clinical and Demographic Factors Associated With Kaposi Sarcoma–Associated Herpesvirus Shedding in Saliva or Cervical Secretions in a Cohort of Tanzanian Women.
- Author
-
Mertelsmann, Anna M, Mukerebe, Crispin, Miyaye, Donald, Shigella, Peter, Mhango, Loyce, Lutonja, Peter, Corstjens, Paul L A M, Dood, Claudia de, Dam, Govert J van, Colombe, Soledad, Maganga, Jane K, Aristide, Christine, Kalluvya, Samuel E, Ward, Maureen M, Cordeiro, Alexandra A, Lee, Myung Hee, Changalucha, John M, and Downs, Jennifer A
- Subjects
- *
HUMAN herpesvirus-6 , *SCHISTOSOMA mansoni , *SALIVA , *SCHISTOSOMA haematobium , *ENDEMIC diseases - Abstract
Background Reasons for the high prevalence of Kaposi sarcoma–associated herpesvirus (KSHV) in sub-Saharan Africa, and risk factors leading to viral reactivation and shedding, remain largely undefined. Preliminary studies have suggested that schistosome infection, which has been associated with impaired viral control, is associated with KSHV. In this study we sought to determine the relationship between active Schistosoma mansoni or Schistosoma haematobium infection and KSHV shedding. Methods We quantified KSHV DNA in saliva and cervical swabs from 2 cohorts of women living in northwestern Tanzanian communities endemic for S mansoni or S haematobium by real-time polymerase chain reaction. χ2 and Fisher exact tests were used to determine differences in clinical and demographic factors between those who were and were not shedding KSHV. Results Among 139 total women, 44.6% were KSHV seropositive. Six percent of those with S mansoni and 17.1% of those with S haematobium were actively shedding KSHV in saliva and none in cervical samples. Women from the S mansoni cohort who were shedding virus reported infertility more frequently (80% vs 19.5%, P =.009). There was no difference in frequency of KSHV salivary shedding between schistosome-infected and -uninfected women. Conclusions In an area with high KSHV seroprevalence and endemic schistosome infections, we provide the first report with data demonstrating no association between schistosome infection and salivary or cervical herpesvirus shedding. KSHV salivary shedding was associated with infertility, a known effect of another herpesvirus, human herpesvirus 6. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Antibody response to malaria vaccine candidates in pregnant women with Plasmodium falciparum and Schistosoma haematobium infections.
- Author
-
Frempong, Naa Adjeley, Mama, Atikatou, Adu, Bright, Kusi, Kwadwo Asamoah, Ofori, Michael F., Ahiabor, Charity, Anyan, William K., Debrah, Alex Yaw, Anang, Abraham A., Ndam, Nicaise T., and Courtin, David
- Subjects
- *
SCHISTOSOMA haematobium , *ANTIBODY formation , *MALARIA vaccines , *PREGNANT women , *PLASMODIUM falciparum - Abstract
Malaria in pregnancy has severe consequences for the mother and foetus. Antibody response to specific malaria vaccine candidates (MVC) has been associated with a decreased risk of clinical malaria and its outcomes. We studied Plasmodium falciparum (Pf) and Schistosoma haematobium (Sh) infections and factors that could influence antibody responses to MVC in pregnant women. A total of 337 pregnant women receiving antenatal care (ANC) and 139 for delivery participated in this study. Pf infection was detected by qPCR and Sh infection using urine filtration method. Antibody levels against CSP, AMA‐1, GLURP‐R0, VAR2CSA and Pfs48/45 MVC were quantified by ELISA. Multivariable linear regression models identified factors associated with the modulation of antibody responses. The prevalence of Pf and Sh infections was 27% and 4% at ANC and 7% and 4% at delivery. Pf infection, residing in Adidome and multigravidae were positively associated with specific IgG response to CSP, AMA‐1, GLURP‐R0 and VAR2CSA. ITN use and IPTp were negatively associated with specific IgG response to GLURP‐R0 and Pfs48/45. There was no association between Sh infection and antibody response to MVC at ANC or delivery. Pf infections in pregnant women were positively associated with antibody response to CSP, GLURP‐R0 and AMA‐1. Antibody response to GLURP‐R0 and Pfs48/45 was low for IPTp and ITN users. This could indicate a lower exposure to Pf infection and low malaria prevalence observed at delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Prevalence and molecular identification of 'Schistosoma haematobium' among children in Lusaka and Siavonga districts, Zambia
- Author
-
Tembo, Rabecca, Muleya, Walter, Yabe, John, Kainga, Henson, Nalubamba, King S, Zulu, Mildred, Mwaba, Florence, Saad, Shereen Ahmed, Kamwela, Moses, Mukubesa, Andrew N, Monde, Ngula, Kallu, Simegnew Adugna, Mbewe, Natalia, and Phiri, Andrew M
- Published
- 2022
40. Repeated versus single praziquantel dosing regimen in treatment of female genital schistosomiasis: a phase 2 randomised controlled trial showing no difference in efficacy
- Author
-
Louise Thomsen Schmidt Arenholt, Bodo Sahondra Randrianasolo, Tiana Onintsoa Oliva Rabozakandraina, Charles Emile Ramarokoto, Karoline Jøker, Katrina Kæstel Aarøe, Dorthe Brønnum, Caspar Bundgaard Nielsen, Suzette Sørensen, Mads Lumholdt, Martin Jensen, Søren Lundbye-Christensen, Jørgen Skov Jensen, Paul Corstjens, Pytsje Hoekstra, Govert J van Dam, Noriko Kobayashi, Shinjiro Hamano, and Peter Derek Christian Leutscher
- Subjects
Schistosoma haematobium ,female genital schistosomiasis ,praziquantel ,urogenital complaints ,gynaecological manifestations ,Arctic medicine. Tropical medicine ,RC955-962 - Abstract
BackgroundSingle-dose praziquantel (PZQ) for treating urogenital schistosomiasis has been reported as inadequate for achieving significant resolution of female genital schistosomiasis (FGS)-associated cervicovaginal lesions. This randomised controlled trial aimed to assess the efficacy and safety of a repeated PZQ-dosing regimen.MethodsThe trial was conducted among women aged 15 to 34 with FGS-associated cervical lesions living in a Schistosoma haematobium-endemic area of northern Madagascar. A total of 116 women were randomly allocated to either repeated PZQ-dosing (n=58) or a single PZQ dose (n=58). All received an initial PZQ dose of 40mg/kg at baseline. In the repeated-dosing arm, additional doses were given 12 and 24 hours later and again at 5 and 10 weeks. Primary outcome was FGS-related cervical lesions at baseline compared to Week 15 follow-up. Secondary outcomes encompassed pelvic exam abnormalities, urogenital complaints, and biomarkers, including cervicovaginal S. haematobium DNA and circulating anodic antigens (CAA) in serum.ResultsExcluding 21 women who were pregnant or failed to attend follow-up visits, 95 women were eligible for per-protocol treatment effect analysis. A minor and insignificant reduction in cervical lesions was observed in both of the two treatment arms at Week 15 follow-up. A clear tendency towards decline in pelvic exam abnormalities and urogenital complaints in both treatment arm groups was observed. The reduction in number of women testing positive for CAA and mean CAA values was significant in both arms but less so in the single-dose arm. Mild to moderate adverse events of equal proportions were reported in both treatment arm groups.ConclusionFGS-associated cervical lesions appear refractory to PZQ treatment even when this is administered in a repeated-dosing regimen. In contrast, the repeated regimen seems more effective at eliminating the dwelling worm population than the single-dose regimen, as demonstrated by the CAA findings. Irrespective of dosing regimen, pelvic exam abnormalities and urogenital complaints saw equal reductions at follow-up. However, the outcome of our primary study emphasises the need for initiation early in life and a persistently maintained PZQ treatment strategy throughout childhood and adolescence to prevent lesions from establishing in the first place.Clinical trial registrationhttps://clinicaltrials.gov/, dentifier NCT04115072.
- Published
- 2024
- Full Text
- View/download PDF
41. An assessment of gynecological manifestations in women with female genital schistosomiasis with reference to Schistosoma biomarkers, sexually transmitted infections and bacterial vaginosis
- Author
-
Bodo Sahondra Randrianasolo, Karoline Jøker, Louise Thomsen Schmidt Arenholt, Tiana Onintsoa Oliva Rabozakandraina, Charles Emile Ramarokoto, Dorthe Brønnum, Martin Jensen, Søren Lundbye Christensen, Jørgen Skov Jensen, Paul Corstjens, Govert J. van Dam, Noriko Kobayashi, Shinjiro Hamano, and Peter Derek Christian Leutscher
- Subjects
Schistosoma haematobium ,female genital schistosomiasis ,gynecological manifestations ,Schistosoma DNA ,circulating anodic antigens ,sexually transmitted infections ,Arctic medicine. Tropical medicine ,RC955-962 - Abstract
BackgroundAlthough a variety of different gynecological manifestations have been reported in women with female genital schistosomiasis (FGS), causality remains to be established. This study aimed to evaluate the gynecological manifestations in women with FGS in accordance with the status of Schistosoma biomarkers, sexually transmitted infections (STIs), and bacterial vaginosis (BV).MethodsThe study was conducted in an endemic Schistosoma haematobium (Sh) area in northern Madagascar in conjunction with a randomized controlled trial investigating the effects and safety of a praziquantel repeated-dosing regimen for women with FGS-associated cervical lesions. Urogenital complaints, pelvic exam abnormalities, and cervical lesion types were assessed in relation to cervicovaginal Schistosoma DNA, circulating anodic antigen (CAA) in serum, and urinary Sh egg count, in addition to STIs and BV.ResultsAmong the included 116 women with a median of 26 years (range 15 to 35), the distribution of Schistosoma DNA and CAA outcomes, specified as either positive (+) or negative (-), were as follows: +/+ (18.1%), +/- (0%), -/+ (58.6%), and -/- (23.3%). Of the three Schistosoma biomarkers, only Schistosoma DNA and the urogenital complaint of blood in the urine were significantly associated. None of the biomarkers were significantly associated with pelvic exam abnormalities or cervical lesions. Sixty women (52.6%) were diagnosed with STIs and/or BV. A positive status was not significantly associated with any of the gynecological manifestations, except BV and homogeneous yellow sandy patches.ConclusionIt remains uncertain whether biomarkers such as cervicovaginal Schistosoma DNA, serum CAA, and Schistosoma eggs in urine adequately cover the full spectrum of gynecological manifestations reported in women with FGS, including urogenital complaints, pelvic exam abnormalities, and cervical lesions. Moreover, it seems difficult to determine the origin of the different manifestations due to the common co-existence of STIs and/or BV as potential confounders.
- Published
- 2024
- Full Text
- View/download PDF
42. Factors influencing the efficacy of praziquantel in a schistosome-exposed population
- Author
-
Zdesenko, Grace, Woolhouse, Mark, and Mutapi, Francisca
- Subjects
praziquantel ,schistosome ,schistosome-exposed population ,Urogenital schistosomiasis ,Schistosoma haematobium ,parasite ,mass drug administration ,schistosomiasis ,pharmacogenetic studies ,metabolomic studies ,cytochrome P450 enzymes ,PZQ- metabolising cytochrome P450 enzymes ,schistosomiasis control - Abstract
Urogenital schistosomiasis, caused by the Schistosoma haematobium parasite, is a global cause of morbidity and mortality and affects millions of people each year. The mass drug administration (MDA) of praziquantel (PZQ) is a vital intervention to treat schistosome infections and eliminate schistosomiasis as a public health problem. After decades of use, variable PZQ efficacy and persistent schistosome infections have been reported across multiple schistosome-endemic African countries. However, there is a paucity of information on the factors that influence the efficacy of a PZQ treatment and contribute to the persistence of infection, particularly in schistosome-exposed populations where the drug is commonly used. To address this, I examined the factors that influence individual responses to PZQ and how these contribute to variable PZQ efficacy. This focused on alterations to PZQ metabolism, which regulates the concentration of the schistosome-killing PZQ, and thus can be a crucial determinant of PZQ efficacy and adverse drug reactions (ADRs). During a review of published studies, I identified several drug and host-related factors, such as drug-drug interactions (DDIs) and the liver's capacity to metabolise PZQ, that influenced the systemic concentrations of PZQ via altered PZQ metabolism, and discussed the resultant impact on PZQ efficacy. This review also highlighted gaps in the research regarding pharmacogenetic (PGx) and metabolomic studies. Consequently, I characterised PGx variations in PZQ- metabolising cytochrome P450 (CYP) enzymes and determined associations between each detected variant and the efficacy of PZQ treatment in S. haematobium-infected Zimbabweans. Four single nucleotide polymorphisms (SNPs) across the CYP1A2, CYP2D6 and CYP3A5 enzymes were significantly associated with PZQ treatment outcome, including genotypes that increased the odds of an individual clearing or not clearing schistosome infection. A further study using in vivo analyte concentrations detected no associations with PZQ efficacy. Yet, there were significant associations between variants in the CYP1A2 and CYP2C9 enzymes and in vivo analyte concentrations indicative of increased metabolism and decreased PZQ exposure. Both PGx studies provided insight into the drug-gene interactions in schistosome-infected patients during a PZQ treatment and suggested that the PGx impact on PZQ exposure and efficacy may be underestimated in the diverse African populations where PZQ is utilised. To determine if variable PZQ efficacy and persistent schistosome infections occurred during MDAs in Zimbabwe, I identified persistent hotspots of S. haematobium infection prevalence (PPHS) and hotspots of decreasing efficacy of PZQ (EPHS). Further, the risk factors of hotspot emergence were evaluated, and EPHS were not identified as a primary cause for PPHS based on these analyses. Initial infection intensity was significantly higher in PPHS than in responder districts, providing valuable information on the possibility of early identification of persistent schistosome infections to improve on current control strategies. However, there was no clear predictor of EPHS occurrence. Overall, this thesis highlighted key factors that influence an individual's response to a PZQ treatment, including multiple PGx determinants which were previously underreported. Together, this thesis produced significant novel data towards the characterisation of the host factors that contribute towards variable PZQ efficacy, and in the identification of hotspots of persistent infections. Together, these findings will inform policymakers on the factors that influence PZQ efficacy to improve schistosomiasis control and eliminate this disease.
- Published
- 2023
- Full Text
- View/download PDF
43. Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases.
- Author
-
Samah Mohammad Hussein, Assistant Lecturer at Parasitology department
- Published
- 2023
44. Pilot Malacology surveys for the intermediate hosts of schistosomiasis in rural and semi-urban areas of the Moyen-Ogooue province, Gabon
- Author
-
Dejon Agobe, Jean Claude, Kariuki, Henry Curtis, Zinsou, Jeannot Frejus, Honkpehedji, Yabo Josiane, Grobusch, Martin Peter, and Adegnika, Ayola Akim
- Published
- 2022
45. Revealing bovine schistosomiasis in Malawi: Connecting human and hybrid schistosomes within cattle
- Author
-
Alexandra Juhász, Peter Makaula, Lucas J. Cunningham, Sam Jones, John Archer, David Lally, JR, Gladys Namacha, Donales Kapira, Priscilla Chammudzi, E. James LaCourse, Edmund Seto, Sekeleghe A. Kayuni, Janelisa Musaya, and J. Russell Stothard
- Subjects
Urogenital schistosomiasis ,Schistosoma haematobium ,Schistosoma mattheei ,Hybridisation ,One Health ,Medicine (General) ,R5-920 - Abstract
In Malawi, the putative origin of a newly described Schistosoma haematobium-mattheei hybrid human schistosome was assessed upon a seminal molecular parasitological survey of cattle. Using miracidia hatch test (MHT) and carcass inspection at slaughter, mean prevalence of bovine schistosomiasis was 49.1% (95% CI: 43.7–54.6%) and 10.3% (95% CI: 6.0–16.2%) respectively, though significant spatial heterogeneity was noted. Approximately 2.0% of infected cattle, and only those from Mangochi District, shed S. haematobium-mattheei and/or S. haematobium in faeces. To quantify schistosome (re)infection dynamics, where a S. haematobium-mattheei hybrid was present, we undertook a novel pilot GPS-datalogging sub-study within a specific herd of cattle (n = 8) on the Lake Malawi shoreline, alongside a praziquantel (40 mg/kg) treatment efficacy spot check. At sub-study baseline, all GPS-tagged cattle had proven daily water contact with the lake. Each animal was patently infected upon MHT, with older animals shedding less miracidia. At one month review, whilst parasitological cure was 100.0%, from six weeks onwards, (re)infection was first noted in the youngest animal. By three-month review, all animals were patently (re)infected though only miracidia of S. mattheei were recovered, albeit in much lower numbers. To conclude, infection with S. mattheei is particularly common in cattle and demonstrates a previously cryptic burden of bovine schistosomiasis. Within Mangochi District, bovine transmission of both S. haematobium-mattheei hybrids and S. haematobium are now incriminated, with unequivocal evidence of contemporary zoonotic spill-over. Future control of urogenital schistosomiasis here in the southern region needs to develop, then successfully integrate, a One Health approach with appropriate mitigating strategies to reduce and/or contain bovine schistosomiasis transmission.
- Published
- 2024
- Full Text
- View/download PDF
46. Female genital schistosomiasis is a neglected public health problem in Tanzania: Evidence from a scoping review.
- Author
-
Mbwanji, Gladys, Mazigo, Humphrey D., Maganga, Jane K., and Downs, Jennifer A.
- Subjects
- *
SCHISTOSOMIASIS , *SEXUALLY transmitted diseases , *MEDICAL personnel , *MEDICAL care , *SCHISTOSOMA haematobium , *GENITALIA infections - Abstract
Schistosoma haematobium, the parasite that causes urogenital schistosomiasis, is widely prevalent in Tanzania. In addition to well-known effects on the urinary tract, S. haematobium also causes clinically- evident damage to the reproductive tract in approximately half of infected women, which is known as female genital schistosomiasis (FGS). FGS has major gynecologic and social consequences on women's reproductive health, yet little information is available regarding FGS in Tanzania. To cover that gap, we conducted the present scoping review to examine the epidemiology of FGS in Tanzania (both in the mainland and Zanzibar island) and to make recommendations for future work in this area. The available evidence from community-based and hospital-based retrospective studies indicates that FGS is a significant health problem in the country. Very few community-based studies have been reported from mainland Tanzania, and Zanzibar. Our review highlights the scarcity of efforts to address FGS in Tanzania and the need for additional community-based studies. The studies will help us understand the true burden of the disease nationwide, to assess the impact of praziquantel on FGS lesions, and to address social and mental health in relation to FGS. This review emphasizes integration of delivery of FGS related services in primary health care systems through the reproductive health clinics which covers sexually transmitted infections, HIV and cervical cancer screening. These actions are essential if this neglected gynecological disease is to be addressed in Tanzania. Author summary: Female genital schistosomiasis (FGS) caused by Schistosoma haematobium affects mostly the reproductive tract of girls and women in rural and marginalized communities. This disease has been largely neglected by the schistosomiasis endemic communities and public health professionals. The present review aimed at assessing the evidence/epidemiology of FGS among women/girls in Tanzania. Furthermore, the review assessed the availability of information, published literature on FGS including comorbidities that address FGS in Tanzania mainland and Zanzibar islands. The evidence generated was important to inform the need to address FGS key gaps among researchers, healthcare workers and communities. Overall, the findings indicated that the knowledge of FGS was lacking among the endemic communities and healthcare workers. Findings from this review have shown the available gaps in literature on FGS in Tanzania, from very few community-and-hospitals based studies reported from mainland Tanzania, and Zanzibar. To address this gap, further research is essential to understanding the true burden of disease-associated morbidity, to assessing the impact of single dose praziquantel in FGS lesions, to understanding mental health in relation to FGS, and to integrating delivery of FGS related services in primary health care systems. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Genetic characterization of schistosome species from cattle in Côte d'Ivoire.
- Author
-
Giovanoli Evack, Jennifer, Kouadio, Jules N., Achi, Louise Y., Bonfoh, Bassirou, N'Goran, Eliézer K., Zinsstag, Jakob, Utzinger, Jürg, and Balmer, Oliver
- Subjects
- *
SCHISTOSOMA haematobium , *CATTLE , *SPECIES , *GENETIC variation , *JOINTS (Anatomy) - Abstract
Background: Schistosomiasis is a water-based parasitic disease that affects humans, livestock and wild animals. While considerable resources are dedicated to the surveillance, disease mapping, control and elimination of human schistosomiasis, this is not the case for livestock schistosomiasis. Indeed, there are important data and knowledge gaps concerning the species present, population genetic diversity, infection prevalence, morbidity and economic impact. This study aimed to identify circulating schistosome species in cattle across Côte d'Ivoire and to investigate their population diversity and structuring. Methods: Overall, 400 adult schistosomes were collected from slaughtered cattle at six sites across Côte d'Ivoire. Additionally, 114 miracidia were collected from live cattle at one site: Ferkessédougou, in the northern part of Côte d'Ivoire. DNA from all specimens was extracted and the cox1 and ITS1/2 regions amplified and analysed to confirm species. The genetic diversity and structuring of the schistosome populations were investigated using 12 microsatellite markers. Results: All adult schistosomes and miracidia presented Schistosoma bovis mitochondrial cox1 profile. Nuclear ITS1/2 data were obtained from 101 adult schistosomes and four miracidia, all of which presented an S. bovis profile. Genetic diversity indices revealed a deficiency of heterozygotes and signals of inbreeding across all sites, while structure analyses displayed little geographic structuring and differentiation. Cattle in Côte d'Ivoire thus appear to be mono-species infected with S. bovis. Hybrids of Schistosoma haematobium × S. bovis have not been identified in this study. Cattle schistosomes appear to be panmictic across the country. Conclusions: Our results contribute to a deeper understanding of schistosome populations in Ivorian cattle and emphasize a One Health approach of joint human and animal surveillance and prevention and control programmes for schistosomiasis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Urinary Schistosomiasis among Female Secondary School Students in Ndokwa East Local Government Area in Delta State, Nigeria: Knowledge, Risk Factors and Prevalence.
- Author
-
Onwuma, C. E., Ochei, O., Awunor, N. S., Aremu, A. B., and Ucho, E. C.
- Subjects
- *
SECONDARY school students , *SCHISTOSOMIASIS , *SCHISTOSOMA haematobium , *LOCAL government , *DELAYED diagnosis , *HELMINTHIASIS - Abstract
Undiagnosed and untreated cases of urinary schistosomiasis in females usually lead to severe gynaecological complications, collectively known as Female Genital Schistosomiasis. Periodic assessment of schistosomiasis in vulnerable endemic communities will prevent late diagnosis and treatment. This study was conducted to determine the prevalence, knowledge, and risk factors of urinary schistosomiasis among female secondary school students in Ndokwa East Local Government Area, Delta State, Nigeria. A Cross-sectional research design and multi-stage sampling technique were used to select 401 female secondary school students in the Ndokwa East Local Government Area. Participants' urine samples were obtained and examined for Schistosoma haematobium eggs. A questionnaire was administered to collect information on the knowledge of schistosomiasis and exposure to known schistosomiasis risk factors from each participant. Urinary schistosomiasis was not detected in any of the analysed samples. Most students were uneducated (8% had good knowledge) regarding the infection. The absence of egg-patent prevalence in the samples may be due to mass administration of praziquantel to control the disease in the LGA. Knowledge about the disease was low. None of the independent variables was a significant predictor of knowledge about urinary schistosomiasis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Impact of Schistosoma sp., Infection on Biological, Feeding, Physiological, Histological, and Genotoxicological Aspects of Biomphalaria alexandrina and Bulinus truncatus Snails.
- Author
-
Dokmak, Hebat-Allah A., Hammam, Olfat A., and Ibrahim, Amina M.
- Subjects
BIOMPHALARIA ,SCHISTOSOMA ,SNAILS ,SCHISTOSOMA mansoni ,SCHISTOSOMA haematobium ,TREMATODA - Abstract
Background: Trematode infections of the genus Schistosoma can induce physiological and behavioral changes in intermediate snail hosts. This is because the parasite consumes essential resources necessary for the host's survival, prompting hosts to adapt their behavior to maintain some level of fitness before parasite-induced mortality occurs. Methods: In this study, the reproductive and biochemical parameters of Biomphalaria alexandrina and Bulinus truncatus were examined during the cercareal shedding stage of infection with Schistosoma mansoni and Schistosoma haematobium, respectively, compared with controls. Results: The study revealed an infection rate of 34.7% for S. mansoni and 30.4% for S. haematobium. In B. alexandrina infected with S. mansoni, a survival rate of 65.2% was recorded, along with a mean prepatent period of 30.3 ± 1.41 days, a mean shedding duration of 14.2 ± 0.16 days, and a mean lifespan of 44.1 ± 0.24 days. Meanwhile, in B. truncatus infected with S. haematobium, a survival rate of 56.4% was observed, with a mean prepatent period of 44.3 ± 1.41 days, a mean shedding duration of 22.6 ± 2.7 days, and a mean lifespan of 66.9 ± 1.6 days. Feeding increased in both infected species of snails, while the net reproductive rate (Ro) of the infected snails decreased. Total antioxidant (TAO) and lipid peroxidation activity increased in the two infected snail species during shedding, while Glutathione-S-transferase levels decreased. Lipid peroxidase activity and nitrogen oxide levels significantly decreased in infected B. alexandrina and increased in infected Bulinus. Steroid hormone levels were elevated in infected Biomphalaria, whereas they were reduced in infected Bulinus. Comet assay parameters showed an increase in the two infected genera after infection compared to control snails, indicating genotoxic damage and histopathological damage was observed. Conclusions: These findings demonstrate that infection with larva species diverse biochemical, hormonal, genotoxic, and histopathological changes in the tissues responsible for fecundity and reproduction in B. alexandrina and B. truncates comparing with controls. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Detection of Parasites in the Field: The Ever-Innovating CRISPR/Cas12a.
- Author
-
Li, Xin, Dang, Zhisheng, Tang, Wenqiang, Zhang, Haoji, Shao, Jianwei, Jiang, Rui, Zhang, Xu, and Huang, Fuqiang
- Subjects
CRISPRS ,PLASMODIUM ,PLASMODIUM falciparum ,NUCLEIC acid amplification techniques ,SCHISTOSOMA haematobium ,NUCLEIC acids ,BLOOD parasites - Abstract
The rapid and accurate identification of parasites is crucial for prompt therapeutic intervention in parasitosis and effective epidemiological surveillance. For accurate and effective clinical diagnosis, it is imperative to develop a nucleic-acid-based diagnostic tool that combines the sensitivity and specificity of nucleic acid amplification tests (NAATs) with the speed, cost-effectiveness, and convenience of isothermal amplification methods. A new nucleic acid detection method, utilizing the clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas) nuclease, holds promise in point-of-care testing (POCT). CRISPR/Cas12a is presently employed for the detection of Plasmodium falciparum, Toxoplasma gondii, Schistosoma haematobium, and other parasites in blood, urine, or feces. Compared to traditional assays, the CRISPR assay has demonstrated notable advantages, including comparable sensitivity and specificity, simple observation of reaction results, easy and stable transportation conditions, and low equipment dependence. However, a common issue arises as both amplification and cis-cleavage compete in one-pot assays, leading to an extended reaction time. The use of suboptimal crRNA, light-activated crRNA, and spatial separation can potentially weaken or entirely eliminate the competition between amplification and cis-cleavage. This could lead to enhanced sensitivity and reduced reaction times in one-pot assays. Nevertheless, higher costs and complex pre-test genome extraction have hindered the popularization of CRISPR/Cas12a in POCT. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.